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Influence Of Local And Circuit-Wide Modulation Of The Mesocorticolimbic
Reward System On The Reinstatement Of Cocaine Seeking
Abstract
Cocaine abuse poses a significant public health concern both in the United States and across the globe. A
critical issue with cocaine abuse is the discouragingly high rate of relapse among addicts following
detoxification and abstinence. The research presented in this doctoral dissertation examines the
influence of local and circuit-wide modulation of the mesocorticolimbic reward system on cocaine
reinstatement, an animal model of relapse.
The data presented in the second and third chapters of this dissertation demonstrate that DBS may serve
as a possible non-pharmacological therapeutic intervention in the treatment of cocaine addiction. In
Chapter 2, I show that DBS of the nucleus accumbens shell attenuates the cue-induced reinstatement of
cocaine seeking, expanding upon previous work demonstrating the efficacy of accumbal shell DBS in
attenuating cocaine priming-induced reinstatement. In Chapter 3, I demonstrate that DBS of the medial
prefrontal cortex (mPFC), but not the basolateral amygdala (BLA) or the ventral hippocampus (vHipp)
selectively attenuates the reinstatement of cocaine seeking. Moreover, this effect is constrained to the
infralimbic subregion of the mPFC as DBS in the prelimbic or anterior cingulate cortices has no effect on
cocaine reinstatement. Further, my results also suggest that infralimbic mPFC DBS attenuates cocaine
reinstatement by disrupting glutamatergic transmission to the nucleus accumbens.
The data presented in Chapter 4 of this dissertation support a substantial body of evidence
demonstrating that increased transmission through GluA1-containing AMPA receptors (AMPARs) in the
nucleus accumbens shell promotes cocaine reinstatement. These data reveal the novel role of the
protein, AKAP150, in the reinstatement of cocaine seeking. My findings indicate that AKAP150 promotes
cocaine reinstatement by facilitating D1-like dopamine receptor (D1DR)-induced, PKA-mediated
phosphorylation of GluA1-containing AMPARs. Collectively, these findings suggest that AKAP150 may
serve as a biochemical bridge linking the dopamine and glutamate systems in the nucleus accumbens
during cocaine reinstatement.
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ABSTRACT
INFLUENCE OF LOCAL AND CIRCUIT-WIDE MODULATION OF THE
MESOCORTICOLIMBIC REWARD SYSTEM ON THE REINSTATEMENT OF
COCAINE SEEKING

Leonardo Antonio Guercio
R. Christopher Pierce, Ph.D.
Heath D. Schmidt, Ph.D.

Cocaine abuse poses a significant public health concern both in the United States and
across the globe. A critical issue with cocaine abuse is the discouragingly high rate of
relapse among addicts following detoxification and abstinence. The research presented
in this doctoral dissertation examines the influence of local and circuit-wide modulation
of the mesocorticolimbic reward system on cocaine reinstatement, an animal model of
relapse.

The data presented in the second and third chapters of this dissertation demonstrate
that DBS may serve as a possible non-pharmacological therapeutic intervention in the
treatment of cocaine addiction. In Chapter 2, I show that DBS of the nucleus accumbens
shell attenuates the cue-induced reinstatement of cocaine seeking, expanding upon
previous work demonstrating the efficacy of accumbal shell DBS in attenuating cocaine
priming-induced reinstatement. In Chapter 3, I demonstrate that DBS of the medial
prefrontal cortex (mPFC), but not the basolateral amygdala (BLA) or the ventral
hippocampus (vHipp) selectively attenuates the reinstatement of cocaine seeking.
Moreover, this effect is constrained to the infralimbic subregion of the mPFC as DBS in
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the prelimbic or anterior cingulate cortices has no effect on cocaine reinstatement.
Further, my results also suggest that infralimbic mPFC DBS attenuates cocaine
reinstatement by disrupting glutamatergic transmission to the nucleus accumbens.

The data presented in Chapter 4 of this dissertation support a substantial body of
evidence demonstrating that increased transmission through GluA1-containing AMPA
receptors (AMPARs) in the nucleus accumbens shell promotes cocaine reinstatement.
These data reveal the novel role of the protein, AKAP150, in the reinstatement of
cocaine seeking. My findings indicate that AKAP150 promotes cocaine reinstatement by
facilitating D1-like dopamine receptor (D1DR)-induced, PKA-mediated phosphorylation
of GluA1-containing AMPARs. Collectively, these findings suggest that AKAP150 may
serve as a biochemical bridge linking the dopamine and glutamate systems in the
nucleus accumbens during cocaine reinstatement.

In sum, the findings presented herein expand our understanding of the neurobiological
mechanisms underlying cocaine seeking and identify both a non-pharmacological
application, deep brain stimulation (DBS), and a novel biochemical target, AKAP150, for
potential therapeutic interventions in cocaine addiction and craving.
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Chapter 1
COCAINE ADDICTION AND RELAPSE: A GENERAL INTRODUCTION
Leonardo Antonio Guercio

“... I sneered at the poor mortals condemned to live in this valley of tears while I,
carried on the wings of two leaves of coca, went flying through the spaces of
77,438 words, each more splendid than the one before... An hour later, I was
sufficiently calm to write these words in a steady hand: God is unjust because he
made man incapable of sustaining the effect of coca all life long. I would rather
have a life span of ten years with coca than one of
10,000,000,000,000,000,000,000 centuries without coca.”
- Paolo Mantegazza, Sulle Virtù Igieniche e Medicinali della Coca e sugli
Alimenti Nervosi in Generale (1859)

Cocaine: A Brief History
Cocaine is derived from the leaves of the coca plant (Erythroxylon coca), a bushlike
flower that is indigenous to the Andean mountain range of northwestern South America,
particularly Colombia, Peru, and Bolivia. For over 4,000 years, the coca leaf has been
chewed or brewed in tea in order to relieve fatigue from working in high altitudes (Karch,
2005). The coca plant was first introduced into Europe in the 16th century, following the
Spanish invasion of Peru and the Incan empire, led by Francisco Pizarro in 1532
(MacQuarrie, 2008). However, cocaine did not become popular in Europe until the mid19th century, when it was isolated from the coca plant.
In 1860, German chemist Albert Niemann, recognizing the powerful stimulant properties
of the coca plant, extracted the pure chemical, cocaine hydrochloride, as part of his
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dissertation work. In the 1880s, Karl Koller, an Austrian ophthalmologist, discovered the
anesthetic properties of cocaine, which led to its use in eye surgery, and later dentistry
(Karch, 2005). In 1884, the eminent Austrian psychiatrist Sigmund Freud published a
book entitled Uber Coca (“On Coca”), in which he touted the many benefits of cocaine,
including its use as an aphrodisiac, mental stimulant, digestive aid, antidepressant,
among others. Freud was so enamored with the drug, he erroneously believed that
chronic cocaine use was not detrimental to the body and that cocaine could also serve
as a treatment for alcohol and morphine addiction, which ultimately led to the death of
his best friend for whom he prescribed cocaine to cure his morphine addiction (Karch,
2005).
In addition to being used for medical purposes, cocaine was also being used
recreationally. In the late 19th century, Parke, Davis & Company sold a medicinal kit that
included 300 mg of powdered cocaine, dissolving solution, and a syringe for intravenous
injection (Karch, 2005). Also at this time, Vin Mariani, a Bordeaux wine infused with
cocaine became wildly popular, bolstered by resounding endorsements from Queen
Victoria of England, Thomas Edison, Ulysses S. Grant, and many others. Pope Leo XIII
even awarded the wine with a Vatican gold medal, in addition to appearing on posters
endorsing the wine (Inciardi, 1992). The success of Vin Mariani ultimately led American
pharmacist John Pemberton to develop a non-alcoholic form of the beverage, since the
state of Georgia had strict prohibition laws at the time. His formula consisted of
approximately 2.5 mg of cocaine (from coca leaves) per 100 mL of caffeinated fluid (from
kola nuts), and he called it Coca-Cola (Spillane, 2000). Even today, the Coca-Cola
recipe still contains coca leaves for flavor, albeit without cocaine (Karch, 2005).
By the early 20th century, increased recreational use of cocaine and improved
knowledge of its addictive properties caused a backlash against drug use, ultimately
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leading to the passage of the Harrison Narcotics Act of 1914, which criminalized the use
of cocaine (Flynn, 1993). The counterculture movement of the 1960s and 1970s led to a
re-emergence of cocaine use due to a more relaxed attitude towards drugs (Miller,
2014). Cocaine use further skyrocketed in the 1980s with the advent of crack cocaine, a
freebase form of cocaine that can be smoked and thereby directly inhaled into the lungs
(Karch, 2005). Though the market for illegal cocaine grew most dramatically in the
1980s, it remains a global crisis with approximately 850 tons of cocaine produced in
2014 (Crime, 2016).

Cocaine Addiction: A Global Public Health Concern
Drug addiction is a major public health concern in both the United States and worldwide.
It is estimated that the total costs of substance abuse including productivity, health, and
crime-related costs, exceed $600 billion annually in the United States alone (National
Drug Intelligence Center, 2011). Cocaine is the fourth most commonly abused illegal
drug in the world, with the United States as the global leader in cocaine demand (Crime,
2016). Approximately 1.5 million Americans aged 12 or older are regular users of
cocaine, comprising about 0.5% of the US population (Sarra L Hedden, 2015). Cocaine
use is also responsible for over 500,000 emergency room visits annually (National
Institute on Drug Abuse, 2016). Thus, cocaine addiction is a prohibitively expensive
public health epidemic that affects millions of Americans.

Physiological Effects of Cocaine Use
Cocaine is a biogenic amine transporter inhibitor, exerting its effects on the dopamine,
serotonin, and norepinephrine systems (Ritz et al., 1990). Cocaine can also block
voltage-gated sodium channels, making it an effective local anesthetic (O'Leary and
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Hancox, 2010). The acute effects of cocaine include euphoria, elation, increased energy,
increased mental alertness, decreased appetite, increased sensitivity to sights, sounds,
and touch, blood vessels constriction, dilated pupils, increased body temperature, and
increased heart rate and blood pressure (Karch, 2005). Chronic cocaine use can lead to
addiction, increased irritability, restlessness, panic attacks, paranoia, psychosis, auditory
hallucinations, heart attacks, increased risk for stroke and seizures, gastrointestinal tears
or ulcerations, septal necrosis, loss of sense of smell, lung damage (typically from crack
cocaine inhalation), sleep disturbances, and malnourishment (National Institute on Drug
Abuse, 2016). Chronic cocaine users typically develop increased tolerance to the drug,
which can lead to compulsive drug-seeking behavior and worsening withdrawal
symptoms (Wolf, 2010).

Drug Abuse and the Cycle of Addiction
Substance use disorders can range from mild to severe and is determined by the
number of diagnostic criteria met by the individual. A diagnosis of substance use
disorder is based on evidence of impaired control, social impairment, risky use, and
pharmacological criteria. The most commonly abused substances are alcohol, tobacco,
cannabis, stimulants, opioids, and hallucinogens. Cocaine is the most widely abused
psychostimulant (Sarra L Hedden, 2015).

Following the initial use of cocaine, drug use can quickly escalate in certain individuals.
These individuals subsequently enter a cycle of chronic drug taking followed by periods
of abstinence and subsequent relapse into chronic drug taking. In fact, one of the major
problems facing cocaine addicts is the discouragingly high rate of relapse, even after
prolonged abstinence (Carroll, 1994; O'Brien, 1997). In fact, rates of relapse increase as
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time goes on — a phenomenon called incubation of craving (Gawin and Kleber, 1986).
Since drug craving increases over time, long-term abstinence is an extraordinarily
difficult accomplishment for addicts. However, despite many years of preclinical and
clinical research focused on understanding the underlying neurobiological and
neurochemical basis of addiction, there are no FDA-approved pharmacotherapeutic
interventions for the treatment of cocaine abuse and relapse.

Modeling Cocaine Taking and Relapse: Self-Administration and Reinstatement
Cocaine craving and relapse in abstinent addicts can be precipitated by 3 major factors:
stress, environmental stimuli previously associated with drug taking, or re-exposure to
the drug itself (Wit and Stewart, 1981; Jaffe et al., 1989; O'Brien et al., 1992; Sinha et
al., 1999). In order to gain a better understanding into the molecular and physiological
underpinnings of cocaine addiction and relapse, researchers utilize an animal model of
addiction, specifically the self-administration/extinction/reinstatement paradigm (Shalev
et al., 2002; Shaham and Hope, 2005; Bossert et al., 2013). This involves training an
animal to self-administer cocaine via operant conditioning. After a period of selfadministration (typically several hours per day for 14-21 days), the cocaine solution is
removed and replaced with saline, which extinguishes cocaine taking. Following
extinction of drug taking, exposure to a stressor, re-exposure to cocaine-associated
cues, or a non-contingent priming injection of cocaine reinstate drug-seeking behavior
(Shalev et al., 2002). This model is invaluable for assessing the neurobiological
underpinnings of drug addiction and craving-induced relapse of cocaine-seeking
behavior.

Neuronal Circuitry Underlying Cocaine Reinstatement

5

Though cocaine can inhibit transporter activity of the dopamine, serotonin, and
norepinephrine systems (Ritz et al., 1990), several studies have shown that dopamine is
the critical biogenic amine underlying the reinstatement of cocaine seeking.
Administration of a dopamine, but not serotonin or norepinephrine, reuptake inhibitor
reinstated cocaine seeking (Schenk, 2002; Schmidt and Pierce, 2006a). Dopaminergic
neurons in the ventral tegmental area (VTA) richly innervate corticolimbic nuclei,
including the nucleus accumbens, medial prefrontal cortex (mPFC), amygdala,
hippocampus, and ventral pallidum (Berendse et al., 1992; Brog et al., 1993; Heimer et
al., 1997). Several of these corticolimbic nuclei, including the medial prefrontal cortex
(mPFC), hippocampus, and amygdala send robust glutamatergic projections to the
nucleus accumbens (Phillipson and Griffiths, 1985; Friedman et al., 2002). The nucleus
accumbens sends efferent GABAergic projections to the VTA and ventral pallidum
(Heimer et al., 1991; Groenewegen et al., 1999), which in turn, send efferent GABAergic
projections to the mediodorsal thalamus (Groenewegen, 2003). The mediodorsal
thalamus sends glutamatergic projections to the mPFC, effectively closing this circuit
(see Figure 1.1).

The nucleus accumbens can be further divided into two functionally segregated
subregions, the medial shell and the lateral core (Meredith et al., 1992; Groenewegen et
al., 1999). The nucleus accumbens shell, considered part of the limbic system, has been
implicated primarily in the reinforcing and rewarding properties of drugs of abuse (Di
Chiara and Imperato, 1988; Pontieri et al., 1995; William A Carlezon and Wise, 1996).
The nucleus accumbens core, considered an extension of the basal ganglia, contributes
to drug-associated, cue-induced drug seeking (Di Ciano and Everitt, 2004; Fuchs et al.,
2004; Ito et al., 2004). Therefore, the nucleus accumbens serves to integrate the
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motivational information from the limbic system with the basal ganglia to facilitate an
appropriate behavioral response.

The Role of the Nucleus Accumbens in Cocaine Seeking
Nucleus Accumbens and Priming-Induced Reinstatement of Cocaine Seeking
It is now clear that increased dopamine transmission in the nucleus accumbens
promotes the reinstatement of cocaine seeking. Thus, intra-nucleus accumbens
infusions of dopamine (Cornish and Kalivas, 2000) promoted the reinstatement of
cocaine seeking in rats that previously self-administered cocaine. Co-administration of
the nonselective dopamine receptor antagonist, fluphenazine, blocked the reinstatement
of cocaine seeking precipitated by intra-accumbal infusions of dopamine (Cornish and
Kalivas, 2000). Dopamine transmission is mediated by a family of G-protein coupled
receptors, with 5 subtypes (D1-D5). These receptors subtypes can be further
categorized as D1-like (D1 and D5) or D2-like (D2, D3, D4) based on their sequence
homology and pharmacology (MISSALE et al., 1998; Beaulieu and Gainetdinov, 2011).
There is an extensive literature indicating that dopaminergic transmission through D1like and D2-like dopamine receptors is critical for the reinstatement of cocaine seeking in
the nucleus accumbens (Bossert et al., 2005; Schmidt and Pierce, 2006b).

Systemic administration of D1-like or D2-like dopamine receptor antagonists blocked the
reinstatement of cocaine seeking (Self et al., 1996; Khroyan et al., 2000; Vorel et al.,
2002). Peripheral injections of D2-like dopamine receptor agonists promoted cocaine
priming-induced reinstatement (Self et al., 1996; Khroyan et al., 2000; De Vries et al.,
2002). However, systemically administered D1-like dopamine receptor agonists failed to
promote, and actually attenuated cocaine reinstatement (Self et al., 1996; Khroyan et al.,
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2000; Self et al., 2000), while intra-accumbal shell administration of D1-like dopamine
receptor agonists promoted the reinstatement of cocaine-seeking behavior (Bachtell et
al., 2005; Schmidt et al., 2006; Anderson et al., 2008). These results suggested that
systemic administration of D1-like dopamine receptor agonists activate D1-like
dopamine receptors in other brain regions, which counteract the reinstatement of
cocaine seeking promoted by activation of D1-like dopamine receptors in the nucleus
accumbens. It should be noted, however, that dopaminergic transmission in the core and
shell subregions of the nucleus accumbens have differential effects on cocaine seeking.
Administration of D1-like or D2-like dopamine receptor antagonists in the accumbens
shell, but not the core, blocked priming-induced reinstatement of cocaine seeking
(Anderson et al., 2003; 2005; Bachtell et al., 2005). Consistent with these findings, intraaccumbal shell, but not core, administration of D1-like and D2-like dopamine receptor
agonists promoted the reinstatement of cocaine seeking (Schmidt and Pierce, 2006b).
Collectively, these findings offer evidence that D1-like and D2-like dopamine receptors
play a critical role in cocaine reinstatement and that D1-like dopamine receptors in other
nuclei besides the nucleus accumbens shell may have differential effects on the
reinstatement of cocaine seeking.

Although cocaine increases the extracellular concentration of dopamine, there is
overwhelming evidence that chronic cocaine exposure also affects glutamatergic
transmission, particularly in the nucleus accumbens, which can have profound effects on
neuronal function and alter the behavioral effects of cocaine (Schmidt and Pierce, 2010).
While cocaine has no direct action on glutamatergic neurons or glutamate levels,
withdrawal from repeated exposure to cocaine reduced basal extracellular levels of
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glutamate in the nucleus accumbens (Pierce et al., 1996), an effect due to decreased
activity of the cysteine-glutamate antiporter (Baker et al., 2003a).

Cocaine priming-induced reinstatement is associated with increased extracellular levels
of glutamate in the nucleus accumbens (Cornish et al., 1999; Cornish and Kalivas, 2000;
Park et al., 2002; McFarland et al., 2003). In fact, systemic injections of N-acetyl
cysteine, a pro-drug that increases the activity of the cysteine-glutamate antiporter,
attenuated cocaine priming-induced reinstatement. Glutamate binds to N-methyl-Daspartate (NMDA), α-amino-3-hydroxy-5- methyl-4-isoxazole propionic acid (AMPA), and
metabotropic glutamate (mGluR) receptors, all of which play a role in cocaine
reinstatement (Schmidt and Pierce, 2010).

Intra-accumbal administration of AMPA or an AMPA receptor agonist reinstated cocaine
seeking, whereas intra-accumbal administration of AMPA receptor antagonists
attenuated cocaine priming-induced reinstatement (Cornish et al., 1999; Cornish and
Kalivas, 2000; Famous et al., 2008; Ping et al., 2008). These effects were observed in
both core and shell subregions of the nucleus accumbens. AMPA receptors are
heteromeric, ligand-gated ion channels expressed throughout the brain that are
composed of 4 subunits: GluA1-GluA4, and are also permeable to Ca2+, Na+, and K+.
AMPA receptors have a unique feature where conversion of a glutamine (Q) residue to
an arginine (R) on the GluA2 subunit renders GluA2-containing AMPA receptors
impermeable to calcium (Hume et al., 1991; Rueter et al., 1995). Since most GluA2
subunits are edited in this matter, GluA2-containing AMPA receptors are considered
calcium-impermeable (Tanaka et al., 2000).
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Cocaine reinstatement is associated with the phosphorylation and trafficking of GluA1
and GluA2-containing AMPA receptors. Consistent with these results, suppression of
GluA1 transcription in the accumbens blocked the reinstatement of cocaine seeking
induced by a priming injection of cocaine (Ping et al., 2008). Cocaine reinstatement is
associated with increased phosphorylation and surface expression of GluA1-containing
AMPA receptors and of GluA1 in the accumbens shell, but not the core (Anderson et al.,
2008). Consistent with this, preventing the transport of GluA1-containing AMPA
receptors to the cell surface in the nucleus accumbens shell attenuated priming-induced
reinstatement of cocaine seeking (Anderson et al., 2008). Additionally, extended
withdrawal from cocaine self-administration increased surface expression of GluA1containing, but not GluA2-containing, AMPA receptors in the nucleus accumbens
(Conrad et al., 2008). Cocaine reinstatement is also associated with increased
phosphorylation and decreased surface expression of GluA2-containing AMPA receptors
in the accumbens shell, but not the core (Famous et al., 2008). Disruption of trafficking
of GluA2-containing AMPA receptors attenuated cocaine priming-induced reinstatement
(Famous et al., 2008). Similarly, more recent studies have shown that withdrawal from
cocaine self-administration and incubation of cocaine craving is associated with
increased insertion of GluA1-containing, GluA2-lacking, calcium-permeable AMPA
receptors (CP-AMPARs) in the nucleus accumbens (Mameli et al., 2009; Ferrario et al.,
2010; McCutcheon et al., 2011b). Taken together, these findings suggest that cocaine
reinstatement is associated with increases in accumbal glutamatergic transmission,
mediated in part by the differential trafficking of GluA1 and GluA2 subunits.

Nucleus Accumbens and Cue-Induced Reinstatement of Cocaine Seeking
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Relapse to drug-seeking behavior can be induced by re-exposure to environmental cues
and contexts previously associated with drug taking (O'Brien et al., 1992). This can be
modeled experimentally in three major ways: context-induced reinstatement (Crombag
and Shaham, 2002), discrete cue-induced reinstatement (Meil and See, 1996), and
discriminative cue-induced reinstatement (Weiss et al., 2000). Behavioral findings from
all three models will be outlined below, however, we will primarily focus on discrete cueinduced reinstatement.

As in priming-induced reinstatement, re-exposure to cocaine-associated stimuli resulted
in increased glutamate levels in the nucleus accumbens (Hotsenpiller and Giorgetti,
2001). Systemic or intra-accumbal core administration of baclofen and muscimol
attenuated cue-induced reinstatement of cocaine-seeking behavior (Di Ciano and
Everitt, 2004; Fuchs et al., 2004). Additionally, excitotoxic lesions of the nucleus
accumbens core, but not the shell, attenuated cocaine seeking induced by discrete cues
(Ito et al., 2004). Consistent with these findings, systemic and intra-accumbal core
administration of an AMPA receptor antagonist, or intra-accumbal core administration of
an NMDA receptor antagonist, attenuated cue-induced reinstatement (Di Ciano, 2001;
Bäckström and Hyytiä, 2006; 2007; Zavala et al., 2008) – however, these treatments had
no effect when injected into the accumbens shell. Systemic administration of ceftriaxone,
an antibiotic that enhances glutamate reuptake in synapses, attenuated cocaine cueinduced reinstatement (Sari et al., 2009; Sondheimer and Knackstedt, 2011; Fischer et
al., 2013). Consistent with this, ceftriaxone-mediated attenuation of cueinduced cocaine reinstatement was reversed by blockade of GLT-1, which is responsible
for glutamate reuptake, in the accumbens core, but not the shell (Fischer et al., 2013).
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While the role of the accumbens core is well established for cue-induced reinstatement
of cocaine seeking, there is evidence that the accumbens shell also contributes to cueinduced reinstatement, particularly in context-induced reinstatement. Administration of
baclofen and muscimol into the accumbens shell attenuated the context-induced
reinstatement of cocaine seeking (Fuchs et al., 2008). Additionally, intra-accumbal shell
administration of AMPA/kainate glutamate receptor antagonist CNQX attenuated
context-induced reinstatement of cocaine seeking (Xie et al., 2012). It should be noted,
however, that similar effects were observed in the accumbens core in both cases.
Together, these findings suggest that the nucleus accumbens core, and to a lesser
extent, the accumbens shell, is critical for cue-induced reinstatement of cocaine seeking.

The Role of the mPFC in Cocaine Seeking
The mPFC can be divided into three functional components: the anterior cingulate
cortex, the prelimbic cortex, and the infralimbic cortex (Krettek and Price, 1977), all of
which receive dense dopaminergic projections from the VTA (Heidbreder and
Groenewegen, 2003). These regions can also be segregated into the dorsal mPFC,
which includes the anterior cingulate cortex and dorsal prelimbic cortex, and the ventral
mPFC, which includes the ventral prelimbic and infralimbic cortices (Graybiel et al.,
1990; Steketee, 2003). Notably, these regions have differential glutamatergic projections
to the nucleus accumbens. The dorsal mPFC projects mainly to the nucleus accumbens
core, whereas the ventral mPFC projects primarily to the nucleus accumbens shell
(Berendse et al., 1992; Wright and Groenewegen, 1995; Ding et al., 2001). While there
is strong evidence for the role of the dorsal mPFC in the reinstatement of cocaine
seeking, there is also evidence for the role of the ventral mPFC as well.
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Infusion of dopamine or cocaine into the dorsal mPFC reinstated cocaine seeking
(McFarland and Kalivas, 2001; Park et al., 2002). Consistent with this, administration of
baclofen and muscimol (McFarland and Kalivas, 2001) or TTX (Capriles et al., 2003) into
the prelimbic, but not infralimbic, cortex attenuated cocaine priming-induced
reinstatement. Additionally, administration of nonspecific, D1-like, or D2-like dopamine
antagonists into the prelimbic, but not infralimbic, cortex blocked cocaine reinstatement
(McFarland and Kalivas, 2001; Park et al., 2002; Capriles et al., 2003; Sun and Rebec,
2005). These findings suggest a strong role for dopaminergic transmission in the dorsal
mPFC in cocaine priming-induced reinstatement.

The glutamatergic projections from the mPFC to the nucleus accumbens play a critical
role in the reinstatement of cocaine seeking (Kalivas and O'Brien, 2008; Schmidt and
Pierce, 2010). As mentioned previously, cocaine priming-induced reinstatement is
associated with increased glutamate release in the nucleus accumbens, an effect that
was blocked by pharmacological inactivation of the dorsal mPFC (McFarland et al.,
2003). Consistent with this, reinstatement of cocaine seeking induced by administration
of cocaine directly into the dorsal mPFC was blocked by intra-accumbal administration of
AMPA antagonists (Park et al., 2002). Additionally, repeated cocaine exposure
increased the excitability of glutamatergic projection neurons in the prelimbic cortex
(Hearing et al., 2013), which increased their responsiveness for cocaine (Sun and
Rebec, 2006).

While there is strong evidence for the role of the dorsal mPFC in cocaine reinstatement,
there is also evidence, albeit conflicting, that the ventral mPFC plays a critical role as
well. In one particular study, administration of baclofen and muscimol into the infralimbic
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cortex reinstated cocaine seeking while microinjections of AMPA into this region
attenuated cocaine seeking (Peters et al., 2008). This is inconsistent with the finding that
administration of baclofen and muscimol into either the prelimbic or infralimbic cortices
attenuated cocaine priming-induced reinstatement (Vassoler et al., 2013). Additionally,
recent work has demonstrated that activation of the infralimbic mPFC-accumbens shell
glutamatergic pathway is critical for the reinstatement of heroin and alcohol seeking
(Bossert et al., 2012; Willcocks and McNally, 2013). Further, it has been shown the
infralimbic cortex is involved in the consolidation of memories for the extinction of
cocaine-seeking behavior (LaLumiere et al., 2010). Collectively, these results indicate
that increased dopamine transmission in the mPFC, and glutamatergic transmission
from the mPFC to the nucleus accumbens are critical for the reinstatement of cocaine
seeking.

The Role of the Basolateral Amygdala in Cocaine Seeking
The amygdala is another nucleus that plays a critical role in the reinstatement of
cocaine-seeking behavior. Like the hippocampus and mPFC, it also receives
dopaminergic projections from the VTA (Fallon et al., 1978)and sends glutamatergic
projections to the nucleus accumbens (Phillipson and Griffiths, 1985). The amygdala can
be divided into many subnuclei, several of which have been shown to be involved in
various types of cocaine reinstatement, particularly cue-induced reinstatement of
cocaine seeking (Grimm, 2000; McFarland et al., 2004; Fuchs et al., 2005; Mashhoon et
al., 2009; Stefanik and Kalivas, 2013).

The basolateral amygdala (BLA) has also been implicated in priming-induced
reinstatement of cocaine seeking. Immediate-early genes arc and zif268 in the BLA were
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upregulated following priming-induced reinstatement of cocaine seeking (Ziółkowska et
al., 2011). Consistent with this, lesions of the BLA attenuated cocaine priming-induced
reinstatement (Yun and Fields, 2003). However, inactivation of the BLA using lidocaine
had no effect on priming-induced reinstatement of cocaine seeking (McFarland and
Kalivas, 2001). Administration of NMDA into the BLA reinstated cocaine seeking (Hayes
et al., 2003) and antagonism of D1-like and D2-like dopamine receptors, in the BLA
attenuated cocaine priming-induced reinstatement (Alleweireldt et al., 2006; Di Ciano,
2008). Additionally, pharmacological manipulations in the BLA that promote experiencedependent plasticity enhanced extinction and attenuated cocaine seeking (Xue et al.,
2014). While these results indicate that the BLA is involved in the priming-induced
reinstatement of cocaine seeking, further studies are required to elucidate the precise
mechanisms by which this nucleus contributes to priming-induced reinstatement.

The Role of the Ventral Hippocampus in Cocaine Seeking
The hippocampus, a critical region for memory and reward-related behaviors, can be
segregated into dorsal and ventral regions (Moser and Moser, 1998). The dorsal
hippocampus is critical for spatial memory (Moser et al., 1995), whereas the ventral
hippocampus plays more important role in motivated behaviors (Henke, 1990).
Additionally, these regions have different anatomical connections, with distinct inputs
and outputs (Swanson and Cowan, 1977). The ventral hippocampus is strongly
innervated with dopaminergic projections from the VTA (Gasbarri et al., 1994a; 1994b).
Additionally, the ventral hippocampus is the major output region of the hippocampus
(Groenewegen et al., 1987) with strong projections to the nucleus accumbens,
particularly the accumbens shell (Fanselow and Dong, 2010). Stimulation of the ventral
hippocampus leads to increased extracellular dopamine levels in the nucleus
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accumbens, an effect that was abolished through blockade of glutamate receptors in the
accumbens (Blaha et al., 1997; Taepavarapruk et al., 2000).

There is also evidence for the role of the ventral hippocampus in the reinstatement of
cocaine seeking. Inactivation of the ventral hippocampus with lidocaine blocked cocaine
priming-induced reinstatement (Sun and Rebec, 2003). Consistent with this,
administration of baclofen and muscimol to the ventral hippocampus attenuated cocaine
priming-induced reinstatement (Rogers and See, 2007). These results indicate a role for
the hippocampus, particularly the ventral hippocampus, in the reinstatement of cocaine
seeking.

Taken together, these findings demonstrate that cocaine reinstatement is associated
with both circuit-wide changes in the mesocorticolimbic reward system, as well as
cellular and molecular changes within each of these subnuclei, particularly the nucleus
accumbens. Focusing on circuit-level changes and potential therapeutic value, Chapters
2 and 3 will examine how deep brain stimulation (DBS) in mesocorticolimbic nuclei can
modulate cocaine seeking and which nuclei are optimal targets for clinical studies.

Deep Brain Stimulation
Deep brain stimulation (DBS) was originally developed in the 1950s in order to produce
“reversible lesions” in the brain and was thought to be a potential replacement for the
lobotomy in the treatment of psychiatric disorders (Lozano and Lipsman, 2013).
However, DBS did not achieve widespread acceptance since decent pharmacological
treatments for psychiatric disorders were developed at that time as well. In the 1980s, it
became increasingly apparent that levodopa, the standard pharmacotherapy for
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Parkinson’s disease, both failed to halt the progression of the disease and also led to
debilitating side effects (Benabid et al., 2001) – thus, the interest in DBS as a therapeutic
option re-emerged. In 1987, it was shown that DBS of the thalamus relieved tremors in
Parkinson’s patients (Benabid et al., 1987). A few years later, the same group showed
that DBS of the subthalamic nucleus (STN) ameliorated symptoms in Parkinson’s
patients (Pollak et al., 1993). Due to its highly effective outcomes and minimal side
effects, DBS grew in popularity throughout the 1990s and 2000s (Hariz, 2012). In 1997,
the US Food and Drug administration approved DBS for the treatment of essential
tremor, with approval for the treatment of Parkinson’s disease and dystonia following in
2002 and 2003, respectively.

DBS Mechanism of Action
Despite years of research, the mechanism of action of DBS remains unclear. General
hypotheses in the field suggest that DBS acts via 1) silencing stimulated neurons
through depolarization inactivation and/or activation of GABAergic interneurons or 2)
activation of associated circuit structures. The first hypothesis is supported from several
studies that observed suppressed firing of neuronal populations around the stimulation
electrode (Benazzouz and Hallett, 2000; Kiss et al., 2002; Meissner et al., 2005).
However, there are credible findings suggesting that DBS may produce local activation
(McIntyre et al., 2004; Montgomery and Gale, 2008). Several studies support the second
hypothesis that DBS can produce activation of nearby axons and afferent structures
(Vitek, 2002; McCracken and Grace, 2007; Johnson et al., 2008; Gradinaru et al., 2009;
Vassoler et al., 2013). However, a growing body of evidence suggests that the
mechanism of action of DBS is far more complex than the “local inhibition, distant
excitation” hypothesis, including affecting multiple neurotransmitter systems (Barat et al.,
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2012; Hess et al., 2013; Martinez et al., 2013). It is clear that more research is required
to provide additional insight into the potential mechanisms of DBS and potentially
improve clinical outcomes.

DBS and Drug Addiction
The success of DBS in treating movement disorders paved the way for its use as a
therapeutic modality in psychiatric disorders. Indeed, DBS is being studied in a number
of psychiatric conditions, including obsessive-compulsive disorder, major depression,
eating disorders, Tourette’s syndrome, and drug addiction (Lozano and Lipsman, 2013).
There have been a number of successful case studies that have examined the effects of
DBS on drug addiction. In a pilot study of DBS of the accumbens in 5 patients with
severe alcohol addiction, all subjects reported complete remission of their craving for
alcohol (Müller et al., 2009; 2016). Another case study showed complete remission of
heroin abuse by a patient for 6 years. Remarkably, the patient refrained from drug abuse
during active stimulation for the first 2.5 years and remained abstinent for 3.5 years even
after the stimulation was removed (Zhou et al., 2011). DBS of the nucleus accumbens
was also shown to be effective in alleviating symptoms of severe alcohol dependence in
one case study (Kuhn et al., 2011) and smoking cessation and weight loss in others
(Kuhn et al., 2009; Mantione et al., 2010). In all cases, DBS of the nucleus accumbens
produced no unwanted side effects. The majority of the studies have targeted the
nucleus accumbens shell, though there is evidence that DBS of the STN is effective in
treating drug addiction as well (Rouaud et al., 2010).

Recent preclinical evidence bolsters support for accumbal shell DBS as an effective
treatment for drug addiction. DBS of the nucleus accumbens prevented morphine-
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conditioned place preference (Liu et al., 2008), attenuated cocaine priming-induced
reinstatement of drug seeking (Vassoler et al., 2008; 2013; Hamilton et al., 2015),
reduced cocaine sensitization (Creed et al., 2015), attenuated cue-induced
reinstatement of drug seeking (Guo et al., 2013; Guercio et al., 2015), decreased alcohol
consumption (Knapp et al., 2009; Wilden et al., 2014) and reduced methamphetamine
intake (Batra et al., 2016). Taken together, these clinical and preclinical findings suggest
that DBS of the accumbens shell may serve as a highly effective treatment for
intractable drug addiction.

While DBS may be a potential therapeutic modality in the treatment of cocaine addiction,
it does not shed light on the complicated neurobiology underlying the drug addiction and
relapse. Discouragingly, despite decades of research, the core pathophysiological
mechanism of drug addiction remains unknown. A greater understanding of the
neurobiological circuitry and mechanisms underlying drug addiction will help lead to
improved pharmacotherapies. Thus, chapter 4 of this dissertation will examine how
cellular and molecular changes in the nucleus accumbens contribute to the
reinstatement of cocaine seeking by examining the novel role of a protein, AKAP150.

Bridging the Dopamine and Glutamate Systems in the Nucleus Accumbens in
Cocaine Reinstatement
Long-term neural adaptations in both the dopaminergic and glutamatergic systems are
involved in the drug-associated learning underlying cocaine reinstatement (Jones and
Bonci, 2005; Kauer and Malenka, 2007). Dopaminergic transmission from the VTA to the
nucleus accumbens (Schmidt et al., 2005; Shaham and Hope, 2005), the mPFC
(McFarland and Kalivas, 2001; Park et al., 2002; Capriles et al., 2003), the ventral
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hippocampus (Vorel, 2001; Sun and Rebec, 2003), and BLA (See et al., 2001;
Alleweireldt et al., 2006) contribute to the reinstatement of cocaine seeking. While these
nuclei all send glutamatergic projections to the nucleus accumbens, certain circuits play
more specific roles in various types of cocaine reinstatement (Britt et al., 2012; Bossert
et al., 2013). The interaction between the dopamine and glutamate systems in the
nucleus accumbens, however, is crucial for the reinstatement of cocaine seeking.

The nucleus accumbens is predominately made up of medium spiny neurons that
express either D1-like dopamine receptors or D2-like dopamine receptors (Gangarossa
et al., 2013). Both D1-containing and D2-containing medium spiny neurons receive
glutamatergic projections from the mPFC, hippocampus, and BLA (Papp et al., 2012;
MacAskill et al., 2014), but exhibit different efferent projections (Smith et al., 2013).
Dopamine acts to modulate excitatory input to the accumbens from the mPFC,
hippocampus, and BLA (Jentsch et al., 2000; Goto and Grace, 2008). The medium spiny
neurons in the accumbens integrate information from dopaminergic and glutamatergic
inputs to generate an appropriate behavioral response (Papp et al., 2012).

Protein Kinase A (PKA) Signaling in the Nucleus Accumbens in Cocaine
Reinstatement
D1-like dopamine receptor (D1DR) signaling in the nucleus accumbens shell is critical
for the reinstatement of cocaine seeking (Anderson et al., 2003; Pierce and Kumaresan,
2006; Schmidt et al., 2006; Schmidt and Pierce, 2006b). D1DRs are Gs-coupled
receptors that stimulate the production of cyclic adenosine monophosphate (cAMP),
which ultimately lead to the activation of PKA (MISSALE et al., 1998; Beaulieu and
Gainetdinov, 2011). Chronic exposure to cocaine leads to increased D1DR signaling, as
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well as increased cAMP formation and PKA activity in the nucleus accumbens (Self et
al., 1995; Unterwald et al., 1996; Lu et al., 2003; Anderson and Pierce, 2005).
Consistent with these observations, inhibition of PKA in the nucleus accumbens reduces
cocaine self-administration (Self et al., 1998) and decreases motivation to obtain cocaine
as measured by progressive ratio responding (Lynch and Taylor, 2005). Surprisingly,
intra-accumbal core administration of a PKA inhibitor, Rp-cAMP, promoted the
reinstatement of cocaine seeking (Self et al., 1998). A potential explanation for this
unexpected result is that Rp-cAMPs can also inhibit other cAMP-activated targets, such
as exchange factors directly activated by cAMP (Epacs) (Bos, 2006). Epac activation
leads to increased levels of the GTPase, Rap, which can interact with the Ras/ERK
cascade to modulate ERK-dependent processes (Lin et al., 2003; Johnson-Farley et al.,
2005). There is considerable evidence linking ERK activation in the accumbens core
with cocaine seeking (Edwards et al., 2011; Fricks-Gleason and Marshall, 2011). In
summary, D1DR signaling in the accumbens shell is critical for the reinstatement for
cocaine seeking and D1DR stimulation leads to downstream PKA activation. The role of
PKA in cocaine reinstatement, however, has not been thoroughly characterized.

GluA1 Phosphorylation and Trafficking in the Nucleus Accumbens in Cocaine
Reinstatement
AMPARs play a major role in cocaine-induced synaptic plasticity and cocaine
reinstatement, as detailed above. The carboxy-terminal region of the GluA1 subunit
contains all of the known protein phosphorylation sites, including residues
phosphorylated by PKA, Protein Kinase C (PKC), and Ca2+/calmodulin-dependent
protein kinase II (CaMKII) (Derkach et al., 2007; Anggono and Huganir, 2012). PKC and
CaMKII can phosphorylate GluA1 at several residues, particularly Serine 831 (Ser831).
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Phosphorylation at Ser831 is associated with GluA1 trafficking following cocaine
reinstatement (Anderson et al., 2008; Pierce and Wolf, 2013).

PKA phosphorylation of GluA1 at Ser845 leads to increased open probability of
AMPARs (Banke et al., 2000). PKA phosphorylation of Ser845 also increases the
surface expression of GluA1-containing AMPARs. In cultured accumbal neurons, D1DR
stimulation increased both Ser845 phosphorylation and GluA1 surface expression (Chao
et al., 2002a; 2002b). Consistent with these findings, cocaine reinstatement was
attenuated by intra-accumbal shell administration of AAV10-GluA1-C99, which impairs
the trafficking of GluA1-containing AMPA receptors to the cell surface (Anderson et al.,
2008). Additionally, withdrawal from cocaine self-administration led to both increased
GluA1 surface expression, Ser845 phosphorylation, and increased rectification, which
suggests an increase in in CP-AMPARs (Conrad et al., 2008; McCutcheon et al.,
2011b). Furthermore, withdrawal from cocaine self-administration caused an increase in
the rectification index specifically in D1- but not D2-containing medium spiny neurons in
the accumbens (Pascoli et al., 2014). Together, these findings suggest that
D1DR/PKA/AMPAR signaling in the nucleus accumbens shell is critically involved in
cocaine seeking.

A-Kinase Anchoring Protein 150 (AKAP150) and Neuronal Plasticity
A-Kinase anchoring proteins (AKAPs) are a family of proteins that contain an α-helical
motif that binds the N-terminus of the PKA-RII subunit. By binding PKA and anchoring it
at the synapse, AKAPs facilitate second messenger signaling (Wong and Scott, 2004;
Carnegie et al., 2009). While there are many different forms of AKAPs, AKAP150 is the
best characterized (Wong and Scott, 2004). AKAP150 is a postsynaptic scaffolding
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protein that binds numerous signaling, accessory, receptor, and ion channel proteins
involved in long-term synaptic plasticity (Sanderson and Dell'Acqua, 2011). AKAP150 is
expressed throughout the forebrain, with highest expression seen in the striatum,
including the nucleus accumbens (Glantz et al., 1992; Ostroveanu et al., 2007).
AKAP150 is anchored to the plasma membrane and the post-synaptic density (PSD) in
dendritic spines via interactions with F-actin, phosphatidyniositol-4,5-bisphosphate
(PIP2), and cadherin cell adhesion molecules (Dell'Acqua, 1998; Gomez et al., 2002;
Gorski et al., 2005). In addition to a PKA binding domain, AKAP150 also contains a
membrane-associated guanylate kinase (MAGUK) motif that promotes its interaction
with AMPA and NMDA receptors via binding to scaffolding proteins, PSD-95 and SAP97
(Colledge et al., 2000; Sanderson and Dell'Acqua, 2011). Furthermore, AKAP150
enhances PKA-mediated phosphorylation of AMPARs, especially Ser845 on GluA1
subunits (Colledge et al., 2000; Tavalin et al., 2002). AKAP150 is also known to bind
PKC (Klauck et al., 1996), and can interact with L-type Ca2+ channels via interaction with
a leucine zipper (LZ) domain (Oliveria et al., 2007). The organization of this postsynaptic
assembly suggests that AKAP150 is a critical scaffolding protein that regulates activitydependent signaling processes at synapses.

There is extensive literature suggesting the importance of AKAP150 in mediating
synaptic plasticity and memory formation. Administration of St-Ht31, a cell-permeable
peptide that disrupts PKA binding to AKAP (Carr et al., 1992), into the lateral amygdala
impairs auditory fear memory (Moita et al., 2002). AKAP150 KO mice exhibit impaired
learning of the Morris Water Maze, a spatial memory task. They also show decreased
AMPA currents and impaired LTD in the hippocampus (Tunquist et al., 2008). AKAP150D36 transgenic mice, where the final 36 amino acid residues – which includes the PKA
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binding domain – are deleted, exhibit impaired LTP and LTD (Weisenhaus et al., 2010).
AKAP150-anchored PKA regulates GluA1 phosphorylation and CP-AMPAR synaptic
incorporation in NMDA-receptor mediated LTD (Sanderson et al., 2016). In addition,
sleep deprived mice exhibiting memory deficits show reduced expression of AKAP150
and reduced AMPA receptor phosphorylation (Hagewoud et al., 2009). Interestingly,
many of the cellular and molecular mechanisms underlying learning and memory are
also critically involved in neuronal plasticity associated with cocaine addiction (Kauer
and Malenka, 2007).

Despite extensive investigation on synaptic plasticity and learning mediated via
AKAP150, the role of AKAP150 in drug addiction has been minimally explored.
However, recent evidence shows that AKAP signaling is involved in the reinstatement of
cocaine seeking (Reissner et al., 2011). Disruption of AKAP-PKA binding in the nucleus
accumbens attenuates the reinstatement of cocaine seeking and reduces the postsynaptic density (PSD) content of PKA. AKAP150 is also increased in PSD fractions of
the nucleus accumbens from cocaine-treated rats (Reissner et al., 2011). Together,
these findings strongly suggest that AKAP150 facilitates PKA-mediated plasticity
underlying cocaine seeking.

Summary
As a whole, the work encompassed in this dissertation advances both our understanding
of the basic science underlying cocaine relapse as well as uncovers better therapeutic
modalities for the treatment of cocaine addiction and relapse.
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Figures

Figure 1. 1 Simplified schematic of the mesocorticolimbic reward system.
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Abstract
Stimuli previously associated with drug taking can become triggers that can elicit craving
and lead to relapse of drug-seeking behavior. Here, we examined the influence of deep
brain stimulation (DBS) in the nucleus accumbens shell on cue-induced reinstatement of
cocaine seeking, an animal model of relapse. Rats were allowed to self-administer
cocaine (0.254 mg, i.v.) for 2 h daily for 21 d, with each infusion of cocaine being paired
with a cue light. After 21 d of self-administration, cocaine-taking behavior was
extinguished by replacing cocaine with saline in the absence of the cue light. Next,
during the reinstatement phase, DBS was administered bilaterally into the nucleus
accumbens shell through bipolar stainless steel electrodes immediately prior to reexposure to cues previously associated with cocaine reinforcement. DBS continued
throughout the 2 h reinstatement session. Parallel studies examined the influence of
accumbens shell DBS on reinstatement induced by cues previously associated with
sucrose reinforcement. Results indicated that DBS of the nucleus accumbens shell
significantly attenuated cue-induced reinstatement of cocaine and sucrose seeking.
Together, these results indicate that DBS of the accumbens shell disrupts cue-induced
reinstatement associated with both a drug and a natural reinforcer.
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Introduction
Deep brain stimulation (DBS), originally developed in the 1950s, first achieved
recognition in the 1980s as a potential therapeutic intervention for Parkinson’s disease
and other movement disorders (Lozano and Lipsman, 2013). Due to its highly effective
outcomes, reversibility, and minimal side effects, DBS has grown in popularity over the
past 25 years (Hariz, 2012; Lozano and Lipsman, 2013), garnering FDA approval for the
treatment of several movement disorders.

The success of DBS in treating movement disorders paved the way for its use as a
therapeutic modality in psychiatric disorders. Indeed, DBS is being studied in a number
of psychiatric conditions, including obsessive-compulsive disorder, major depression,
eating disorders, Tourette’s syndrome, and drug addiction (Lozano and Lipsman, 2013;
Müller et al., 2013). This is primarily due to the belief that DBS is relatively safe, free of
unwanted side effects, and in some cases, may even have beneficial effects on
attention, learning and memory, and executive function (Grubert et al., 2011; Bossert et
al., 2013). Although DBS is highly invasive procedure with a surgical fatality rate
estimated at 0.4%, the high costs associated with severe drug addiction have led many
to conclude that DBS as a therapeutic intervention is a valuable avenue of research (Wit
and Stewart, 1981; Müller et al., 2013).

Recent preclinical and clinical studies suggest that deep brain stimulation (DBS) of the
nucleus accumbens, a limbic structure that is critically involved in the reinforcing and
reinstating effects of drugs of abuse, may be a possible therapy in the treatment of drug
addiction (Müller et al., 2013; Pierce and Vassoler, 2013). In a pilot study of DBS of the
accumbens in 5 patients with severe alcohol addiction, all subjects reported complete
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remission of their craving for alcohol (Müller et al., 2009). Another case study showed
complete remission of heroin abuse by a patient for 6 years. Remarkably, the patient
refrained from drug abuse during active stimulation for the first 2.5 years and remained
abstinent for 3.5 years even after the stimulation was removed (Zhou et al., 2011). In all
cases, DBS of the nucleus accumbens produced no unwanted side effects.

In animal models of addiction, DBS of the nucleus accumbens prevented morphineconditioned place preference (Liu et al., 2008), attenuated cocaine priming-induced
reinstatement of drug seeking (Vassoler et al., 2008; 2013), and decreased alcohol
consumption (Knapp et al., 2009). However, although recent work indicates that
accumbens DBS attenuated cue-induced reinstatement of heroin seeking (Guo et al.,
2013), the influence of DBS on cue-induced reinstatement of cocaine seeking is
unknown. Therefore, we examined the effects of DBS in the nucleus accumbens on cueinduced reinstatement of cocaine-seeking as well as sucrose-seeking behavior.

29

Materials and Methods
Animals and housing. Male Sprague-Dawley rats (Rattus norvegicus) weighing 250300g were ordered from Taconic Laboratories (Germantown, NY, USA). Animals were
individually housed with food and water available ad libitum. Animals in the sucrose
reinstatement study received ~25 g chow per day and had water available ad libitum. A
12h light/dark cycle (lights on at 7:00 am) was used and all experiments were performed
during the light cycle. All experimental procedures were consistent with the ethical
guidelines of the U.S. National Institutes of Health and were approved by the University
of Pennsylvania Perelman School of Medicine Institutional Animal Care and Use
Committee.

Materials. All experiments used Med-Associates (East Fairfield, VT, USA) operant
chambers equipped with response levers, house light, cue light, pumps for injecting
drugs intravenously, and food hoppers for dispensing sucrose pellets. Operant
chambers were enclosed within ventilated, sound attenuating chambers.

Surgery. Prior to surgery, the rats were injected intraperitoneally with 80 mg/kg ketamine
and 12 mg/kg xylazine (Sigma-Aldrich; St. Louis, MO, USA). An indwelling silastic
catheter was placed into the right jugular vein (side opposite the heart) and sutured in
place. The catheter was then threaded subcutaneously over the shoulder blade and was
routed to a mesh backmount platform (CamCaths, UK) that was sutured below the skin
between the shoulder blades. Catheters were flushed daily with 0.3 ml of an antibiotic
(Timentin, 0.93 mg/ml; Henry Schein, Melville, NY, USA) dissolved in heparinized saline.
Catheters were sealed with plastic obturators when not in use.
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After catheter implantation, the rats were mounted in a stereotaxic apparatus (Kopf
Instruments; Tujunga, CA, USA) and bipolar stainless steel electrodes (Plastics One;
Roanoke, VA, USA) were implanted into to the nucleus accumbens shell according to
the following coordinates, relative to bregma (Paxinos and Watson, 1997): + 1.0 mm
anteroposterior (A/P), +/– 3.0 mm mediolateral (M/L), – 7.3 mm dorsoventral (D/V). The
stereotaxic arms were set at a 17° angle. Electrodes were cemented in place by affixing
dental acrylic to three stainless steel screws fastened to the skull.

Cocaine self-administration, extinction, and cue-induced reinstatement of drug seeking.
Following a 7 d recovery period, the rats were placed in operant chambers and were
allowed to press a lever for intravenous cocaine infusions (0.254 mg of cocaine
dissolved 59 µL of saline) on a fixed ratio 1 (FR1) schedule of reinforcement. Each
active lever press resulted in an infusion of cocaine and the drug-paired cue (concurrent
illumination of the cue light above the active lever) for 5 s. When stable responding was
achieved with the FR1 schedule (i.e., <15% variation in response rates over 3
consecutive days), they were switched to an FR5 schedule. A 20 s timeout period during
which responses have no scheduled consequences followed each cocaine infusion.
Active lever presses made during the time out were counted but did not result in drug
delivery and inactive lever presses were of no consequence. The rats were limited to a
maximum of 30 cocaine infusions per daily 2 h self-administration session.

After 21 d of cocaine self-administration, the animals underwent an extinction phase
during which cocaine was replaced with saline. Additionally, presses on the active lever
no longer produced presentation of the drug-paired cue light. Daily 2 h extinction
sessions were conducted until responding was <15% of the response rate maintained by
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cocaine self-administration. Following the extinction phase, the ability of re-exposure to
the cue light to reinstate drug-seeking behavior was assessed. For the reinstatement
test sessions, the FR5 schedule was used where active lever presses produced the light
cue that had been presented during self-administration. However, satisfaction of the
response requirements for each component resulted in a saline infusion rather than a
cocaine infusion. Each reinstatement session was followed by extinction sessions until
responding was again <15% of the response rate maintained by cocaine selfadministration. All animals underwent 2 reinstatement sessions, counterbalanced with
respect to whether stimulation was given.

Sucrose self-administration, extinction and cue-induced reinstatement of sucrose
seeking. Rats were trained to self-administer 45 mg sucrose pellets (Research Diets;
New Brunswick, NJ, USA) using the same procedures described above. After 21 days of
daily 1 h food-reinforced operant sessions, rats underwent an extinction phase where
responding no longer resulted in food delivery or cue light presentation. After lever
pressing decreased to 15% or less of the responding maintained by contingent sucrose
reinforcement, animals began reinstatement testing. Reinstatement of sucrose seeking
was promoted by presentation of the cue light. For reinstatement, the FR5 schedule was
used where active lever presses produced the light cue that had been presented during
self-administration. However, satisfaction of the response requirements for each
component did not dispense any sucrose pellets. Each 1 h reinstatement session was
followed by extinction sessions until responding was again <15% of the response rate
maintained by sucrose.

Deep brain stimulation. For DBS experiments, we used alternating current with biphasic
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symmetrical pulses (60 µs pulse width and a 160 Hz frequency) and 150 µA of current,
parameters that are consistent with previous work in this field (Chang et al., 2003;
Mayberg et al., 2005; Vassoler et al., 2013). Immediately before the start of a
reinstatement session, 0 or 150 µA current was delivered continuously to the bipolar
electrodes. The stimulation continued for the duration of the 2 h reinstatement session.
In the 0 µA condition, the electrodes were attached in the exact same manner as the 150
µA condition but DBS was not administered. The 0 and 150 µA currents were
administered in a counterbalanced fashion across the multiple reinstatement test days.

Verification of electrode placements. After the completion of all experiments, the animals
were given an overdose of pentobarbital (100 mg/kg) and perfused intracardially with
0.9% saline followed by 10% formalin. The brains were removed and coronal sections
(100 µm) were taken at the level of the nucleus accumbens with a vibratome (Technical
Products International; St. Louis, MO, USA). Animals with electrode placements outside
of the areas of interest, or with excessive mechanical damage, were excluded from
subsequent data analysis.

Drugs. Cocaine hydrochloride was obtained from the National Institute on Drug Abuse
(Rockville, MD, USA) and dissolved in bacteriostatic 0.9% saline.

Statistics. All reinstatement experiments were analyzed with two-way ANOVAs with
repeated measures over reinstatement days. Pairwise analyses were made with
Bonferroni post-tests (p < 0.05).
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Results
DBS of the accumbens shell attenuates cue-induced reinstatement of cocaine seeking
Following cocaine self-administration and extinction, deep brain stimulation of the
nucleus accumbens shell (0 or 150 µA) was administered throughout the 2 h cueinduced reinstatement test session. Active lever responses (mean±SEM) during the final
days of cocaine self-administration and extinction are shown in Figure 1A. Total active
and inactive lever responses (mean±SEM) from the reinstatement session are presented
in Figure 1B. These data were analyzed using a two-way ANOVA (both treatment and
lever were within-subject factors), which revealed significant main effects of DBS
treatment (F(1,5)=45.53, p<0.0011) and lever (F(1,5)=29.13, p<0.0029), as well as a
significant interaction between these variables (F(1,5)=17.32, p<0.0088). Subsequent
pairwise analyses indicated that the total active lever responses were significantly
different between the 0 and 150 µA treatments during cue-induced reinstatement test
sessions (Bonferroni, p<0.05). The time course data for active lever responding (Figure
1C) were analyzed with a two-way ANOVA (treatment and time were both withinsubject), which revealed significant main effects of DBS treatment (F(1,5)=45.54,
p<0.0011) and time (F(11,55)=9.474, p<0.0001) as well as a significant interaction between
these variables (F(11,55)=5.115, p<0.0001). Subsequent pairwise analyses indicated that
the active lever responses between 0 and 150 µA treatments were significantly different
over the first 10 minutes of the reinstatement session (Bonferroni, p<0.001). The
electrode placements are shown in Figure 1D (n=6). Although inactive lever responding
was somewhat lower in the DBS treatment relative to control (Figure 1B), the low
number of inactive responses limits the ability of this measure to accurately assess
nonspecific rate suppression effects. Therefore, we also assessed the effects of DBS in
the nucleus accumbens shell (0 or 150 µA) on the reinstatement of sucrose seeking.
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DBS of the accumbens shell attenuates cue-induced reinstatement of sucrose seeking
In order to determine if the effects of DBS in the accumbens shell were reinforcer
specific, we tested the effect of DBS in the accumbens shell on sucrose cue-associated
reinstatement. Active lever responses (mean±SEM) during the final days of sucrose
self-administration and extinction are shown in Figure 2A. Total active and inactive lever
responses (mean±SEM) from the reinstatement session during which DBS was
administered to the accumbens shell during cue-induced sucrose reinstatement test
sessions are shown in Figure 2B. These data were analyzed with a two-way ANOVA
(treatment and lever were within-subject factors), which revealed no effect of DBS
treatment (F(1,5)=1.836, p<0.2334), a significant effect of lever (F(1,5)=31.62, p<0.0025)
and a significant interaction between these variables (F(1,5)=9.352, p<0.0282).
Subsequent pairwise analyses indicated that the total active lever responses between
the 0 and 150 µA treatments were significantly different (Bonferroni, p<0.05). The time
course data for active lever responding (Figure 2C) were analyzed with a two-way
ANOVA (treatment and time were within-subject factors), which revealed no significant
effect of DBS treatment (F(1,5)=5.875, p<0.0598), but a significant main effect of time
(F(11,55)=15.73, p<0.0001) as well as a significant interaction between these variables
(F(11,55)=2.094, p<0.0362). Subsequent pairwise analyses indicated that the active lever
responses between 0 and 150 µA treatments were significantly different over the first 10
minutes of the reinstatement session (Bonferroni, p<0.001). All data from one animal
were removed because of highly unusual time course responses in the 0 µA control
condition (162 active lever presses between 40 and 60 minutes with no other presses).
This is well beyond 2 SDs above the mean for this group. Electrode placements for
these studies are shown in Figure 2D (n=6).
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Discussion
We have previously shown that DBS of the accumbens shell attenuated cocaine
priming-induced reinstatement of drug seeking but had no influence on the reinstatement
of sucrose seeking (Vassoler et al., 2013). The current data expand upon these findings
and indicate that DBS of the nucleus accumbens shell also attenuates cue-induced
reinstatement of cocaine and sucrose seeking.

The role of the accumbens core in cue-induced reinstatement of drug seeking is well
established in the literature. Administration of an AMPA/kainate receptor antagonist in
the nucleus accumbens core, but not the shell, reduced cue-induced cocaine-seeking
behavior (Di Ciano, 2001). Additionally, excitotoxic lesions of the core, but not the shell,
markedly attenuated cue-induced reinstatement of cocaine seeking (Ito et al., 2004).
Indeed, the accumbens core plays a critical role in cue-induced reinstatement of other
drugs of abuse as well, including heroin, amphetamine, and even natural rewards such
as sucrose (Di Ciano and Everitt, 2004). While much is known about the accumbens
core and its role in cue-induced reinstatement of drug seeking, the role of the
accumbens shell in cue-induced reinstatement of drug seeking is much more complex.

Most studies have reported no effect or an attenuated effect in cue-induced
reinstatement of drug or food seeking following pharmacological inactivation of the
accumbens shell (Fuchs et al., 2004; Bossert et al., 2007; Lin and Pratt, 2014). Others
have even demonstrated potentiated cue-induced reinstatement of food seeking
following inactivation of the accumbens shell (Floresco et al., 2008). Our results may
differ from these studies as DBS has multiple potential mechanisms of action, including,
but not limited to, inactivation of target brain regions. Additionally, our findings suggest
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that while accumbal shell DBS is effective at attenuating priming-induced reinstatement
(Vassoler et al., 2013), it seems to be a questionable treatment for cue-induced
reinstatement, as it also attenuated cue-induced reinstatement of sucrose seeking
(Figure 2B). Although we show nonspecific behavioral effects of accumbal shell DBS, we
do not believe that these effects are due to generalized motor inhibition, as we do not
see any attenuation in inactive lever responding in either group. Additionally, we have
previously shown that although DBS of the nucleus accumbens shell attenuates the
priming-induced reinstatement of cocaine seeking, it has no effect on the priminginduced reinstatement of sucrose seeking (Vassoler et al., 2008). These findings lead us
to believe that the nonspecific behavioral effects elicited by accumbal shell DBS are not
due to generalized motor inhibition, but rather to the differences between priminginduced and cue-induced reinstatement tasks.

Our present findings show that DBS of the accumbens shell attenuates cue-induced
reinstatement of cocaine and sucrose seeking. As previously stated, preclinical and
clinical literature suggest that DBS of the accumbens is a promising therapeutic modality
in the treatment of addiction, especially due to the lack of unwanted side effects. These
findings suggest that while DBS of the nucleus accumbens shell is a promising
therapeutic modality for the treatment of severe cocaine addiction, clinical trials should
proceed with caution, as there may be nonselective effects of accumbal DBS.
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Figure 2. 1 Deep brain stimulation of the nucleus accumbens shell attenuates cue-induced
reinstatement of cocaine seeking. (A) Mean (±SEM) active lever responses during the final days
of cocaine self-administration and extinction. (B) Mean (±SEM) active and inactive lever
responses from reinstatement sessions with 0 or 150 µA stimulation aimed at the accumbens
shell. (C) Time course of active lever responding from 0 or 150 µA stimulation of the accumbens
shell. (D) Electrode placements from the shell (dark circles). The values are in millimeters,
relative to bregma. *p < 0.001 0 µA compared to 150 µA. There were 6 animals per group.
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Figure 2. 2 Deep brain stimulation of the nucleus accumbens shell attenuates cue-induced
reinstatement of sucrose seeking. (A) Mean (±SEM) active lever responses during the final days
of sucrose self-administration and extinction. (B) Mean (±SEM) active and inactive lever
responses from reinstatement sessions with 0 or 150 µA stimulation aimed at the accumbens
shell. (C) Time course of active lever responding from 0 or 150 µA stimulation of the accumbens
shell. (D) Electrode placements from the shell (dark circles). The values are in millimeters,
relative to bregma. *p < 0.05 0 µA compared to 150 µA. There were 6 animals per group.

39

Chapter 3
Deep Brain Stimulation of the Infralimbic Medial Prefrontal Cortex Attenuates Cocaine
Reinstatement Through Inactivation of Cortico-Striatal Projections
Leonardo A. Guercioa,b, Fair M. Vassolerb, Mathieu E. Wimmerb, Heath D. Schmidtb,c and
R. Christopher Pierceb

a
b

Neuroscience Graduate Group

Center for Neurobiology and Behavior, Department of Psychiatry
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA 19104, USA
c

Center for Biobehavioral Health Sciences
School of Nursing
University of Pennsylvania
Philadelphia, PA 19104

40

Abstract
Deep brain stimulation DBS is a promising therapeutic modality for the treatment of
addiction. To date, most findings have examined the effects of DBS in the nucleus
accumbens in drug addiction. Here, we investigate the effects of DBS in brain regions
that send robust glutamatergic projections to the nucleus accumbens, specifically the
medial prefrontal cortex (mPFC), basolateral amygdala (BLA), and ventral hippocampus
(vHipp) on the priming-induced reinstatement of cocaine seeking, an animal model of
relapse, in male Sprague Dawley rats. The current results demonstrate that DBS in the
infralimbic mPFC, but not the prelimbic or anterior cingulate cortices, attenuates cocaine
reinstatement. We also demonstrate that DBS of the BLA and vHipp attenuate the
reinstatement of both cocaine and sucrose seeking. To examine potential circuit-wide
changes, zif268 immunohistochemistry was used to examine neuronal activity following
DBS of the infralimbic mPFC. We show that infralimbic mPFC DBS is associated with
decreased zif268 immunoreactivity in the nucleus accumbens shell. Our findings
suggest that infralimbic mPFC DBS attenuates cocaine reinstatement by disrupting
glutamatergic transmission to the nucleus accumbens. These results support previous
claims that the mPFC may be an effective target for DBS in the treatment of addiction.
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Introduction
Cocaine abuse is a serious public health concern both in the United States and
worldwide. In the United States, cocaine is the third most commonly abused illicit drug,
after marijuana and prescription opiates, with nearly 1 million regular users (SAMHSA,
2014). Despite years of preclinical and clinical research, pharmacological therapies have
met with limited success and there remain no FDA-approved treatments for cocaine
addiction and relapse.

Recent evidence shows that deep brain stimulation (DBS), an FDA-approved treatment
for movement disorders (Lozano and Lipsman, 2013), may be a viable therapeutic
option in the treatment of intractable drug addiction (Müller et al., 2013; Pierce and
Vassoler, 2013). To date, the majority of these studies have focused primarily on the
nucleus accumbens, a limbic structure that plays a critical role in the reinforcing
properties of drugs of abuse, including cocaine. DBS of the nucleus accumbens shell,
but not the core, attenuated both the priming- and cue-induced reinstatement of cocaine
seeking, animal models of relapse (Vassoler et al., 2008; 2013; Guercio et al., 2015).
DBS of the accumbens shell also suppressed locomotor sensitization to cocaine (Creed
et al., 2015), another behavioral task that reflects aspects of plasticity related to drug
craving (Robinson and Berridge, 2001; Steketee and Kalivas, 2011). However, since
DBS is a highly invasive procedure, with a surgical fatality rate of approximate 0.5%
(Müller et al., 2013), it is critical to determine if there are other promising target areas
with high effectiveness, safety, and feasibility in treating drug addiction. The role of the
nucleus accumbens in cocaine reinstatement is well known. However, other
mesocorticolimbic nuclei contribute heavily to the reinstatement of cocaine seeking
(Schmidt et al., 2005). In particular, the medial prefrontal cortex (mPFC), ventral
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hippocampus (vHipp), and basolateral amygdala (BLA) send rich glutamatergic
projections to the nucleus accumbens (Phillipson and Griffiths, 1985; Friedman et al.,
2002) and are critical for the reinstatement of cocaine seeking (Grimm, 2000; McFarland
and Kalivas, 2001; Sun and Rebec, 2003; Schmidt and Pierce, 2010; Lüscher and
Malenka, 2011). We sought to determine whether these nuclei could also serve as target
regions for DBS in the treatment of cocaine addiction.

The underlying mechanism of DBS remains unclear. We have previously shown that the
attenuation of cocaine reinstatement by accumbal shell DBS is not due to inactivation of
the medium spiny neurons as intra-accumbal shell infusion of GABA agonists, baclofen
and muscimol, or lidocaine, did not mimic the effects seen with DBS (Vassoler et al.,
2013). In fact, DBS of the accumbens shell promoted antidromic activation of GABAergic
interneurons in the mPFC (Vassoler et al., 2013). This is consistent with
electrophysiological evidence indicating that accumbens DBS inhibited spontaneous
activity of cortico-accumbal glutamatergic projection neurons, while antidromically
stimulating cortical interneurons (McCracken and Grace, 2007). Recent evidence
indicated that DBS of the nucleus accumbens leads to decreased extracellular levels of
glutamate and increased levels of GABA in rats that had been exposed to morphine
(Yan et al., 2013). Another study showed that increases in GABA concentration
mediated by accumbal DBS were attenuated by pre-treatment with memantine, an
NMDA receptor antagonist (Varatharajan et al., 2015). These results suggest that DBS
of glutamatergic projections to the nucleus accumbens may modulate the reinstatement
of cocaine seeking.
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In the current study, we investigated the effects of DBS in brain regions that send robust
glutamatergic projections to the nucleus accumbens, specifically the mPFC, BLA, and
vHipp, on the reinstatement of cocaine seeking. Moreover, we examined immediateearly gene activation in the nucleus accumbens to examine potential mechanisms that
may contribute to the effects of DBS on cocaine reinstatement. Our results suggest that
DBS attenuates cocaine reinstatement by disrupting glutamatergic transmission to the
nucleus accumbens.
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Materials and Methods
Animals and housing: Male Sprague-Dawley rats (Rattus norvegicus) weighing 250-300
g were obtained from Taconic Laboratories (Germantown, NY). Rats were individually
housed with food and water available ad libitum. A 12/12 hr light/dark cycle was used
with the lights on at 7:00 a.m. All experimental procedures were performed during the
light cycle. All experimental procedures were consistent with the ethical guidelines of the
US National Institutes of Health and were approved by the Perelman School of Medicine
Institutional Animal Care and Use Committee at the University of Pennsylvania.

Materials: All experiments used Med-Associates (East Fairfield, VT) instrumentation
enclosed within ventilated, sound attenuating chambers. Each operant conditioning
chamber was equipped with response levers, stimulus lights, food pellet dispensers and
injection pumps for injecting drugs intravenously.

Surgery: Prior to surgery, rats were anesthetized with 80 mg/kg ketamine and 12 mg/kg
xylazine. An indwelling silastic catheter was placed into the right jugular vein (side
opposite the heart) and sutured in place. The catheter was then threaded
subcutaneously over the shoulder blade and was routed to a mesh backmount platform
(CamCaths, Cambridge, UK/ Strategic Applications Inc., Libertyville, Il) that was sutured
below the skin between the shoulder blades. Catheters were flushed daily with 0.3 ml of
an antibiotic (Timentin, 0.93 mg/ml) dissolved in heparinized saline. The catheters were
sealed with plastic obturators when not in use.Following catheter implantation, the rats
were mounted in a stereotaxic apparatus (Kopf Instruments, CA) and bipolar stainless
steel electrodes (Plastics One, Roanoke, VA) were trimmed and implanted into to the
basolateral amygdala, ventral hippocampus, infralimbic medial prefrontal cortex,
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prelimbic medial prefrontal cortex, or anterior cingulate prefrontal cortex according to the
following coordinates, relative to bregma (Paxinos and Watson, 1997): basolateral
amygdala: -2.8 mm anteroposterior (A/P), ±5.0 mm mediolateral (M/L), -8.5 mm
dorsoventral (D/V); ventral hippocampus: -5.5 mm A/P, ±5.0 mm M/L, -6.5 mm D/V;
infralimbic prefrontal cortex: +2.5 mm A/P, ±2.0 mm M/L, -5.39 mm D/V, 21.78° angle;
prelimbic prefrontal cortex: +2.5 mm A/P, ±2.0 mm M/L, -4.2 mm D/V, 19.5° angle;
anterior cingulate prefrontal cortex: +2.5 mm A/P, ±2.0 mm M/L, -3.0 mm D/V, 27.8°
angle. Electrodes were cemented in place by affixing dental acrylic to three stainless
steel screws fastened to the skull.

Cocaine self-administration and extinction. Following a 7 d recovery period, rats were
placed in operant conditioning chambers and allowed to press a lever for intravenous
cocaine infusions (0.254 mg of cocaine, 59 µL of saline, infusion over 5 s). Rats initially
were trained using a fixed ratio 1 (FR1) schedule of reinforcement. When the animals
achieved stable responding with the FR1 schedule (i.e., <15% variation in total presses
over 3 consecutive days), they were switched to an FR5 schedule. A 20 s timeout period
during which active, drug-paired lever responses had no scheduled consequences
followed each cocaine infusion. Each operant chamber was also equipped with an
inactive lever. Responses made on the inactive lever had no scheduled consequences.
The rats were limited to a maximum of 30 cocaine infusions per daily 2 h selfadministration session. After 21 d of daily cocaine self-administration sessions, rats
underwent an extinction phase during which cocaine was replaced with 0.9%
bacteriostatic saline. Daily 2 h extinction sessions were conducted until active lever
responding was <15% of the responses averaged over the last 3 days of cocaine selfadministration.
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Sucrose self-administration and reinstatement. Following a 7 d period for recovery from
surgery, separate groups of rats were food restricted (~25 g of daily chow; Harland
Teklad, Wilmington, DE) and allowed to self-administer 50 mg Noyes sucrose pellets
(Research Diets; New Brunswick, NJ, USA) using the same procedures described
above. After 21 d of daily 1 h sucrose-reinforced operant sessions, rats underwent an
extinction phase during which active lever responding no longer resulted in sucrose
delivery. Daily extinction sessions were continued until active lever responding was
<15% of the responses averaged over the last 3 days of sucrose self-administration.
Reinstatement of sucrose seeking was promoted by non-contingent administration of
one sucrose pellet every 2 min during the first 10 min of the reinstatement test session.
Each reinstatement test day was followed by extinction sessions (typically only one or
two) until responding was again <15% of the responses achieved during selfadministration.

Deep brain stimulation. In most DBS experiments (both clinical and preclinical), many
parameters are fixed and uniform across studies. We used alternating current with
biphasic symmetrical pulses (60 µs pulse width and a 160 Hz frequency), parameters
that are consistent with previous work from our lab and others (Chang et al., 2003;
Mayberg et al., 2005; Vassoler et al., 2013). Stimulation intensities, in contrast, are often
varied within and between studies, usually in the range of 50 –200 µA (Benazzouz and
Hallett, 2000; Chang et al., 2003; Mayberg et al., 2005). We previously reported that 150
µA of current is an effective stimulation intensity in our reinstatement paradigm (Vassoler
et al., 2008). Immediately before the start of a reinstatement session, 0 or 150 µA
current was delivered continuously to the bipolar electrodes. The stimulation continued
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for the duration of the 2 h reinstatement session. Throughout the 0 µA condition, the
stimulation tethers were attached in the exact same manner as the 150 µA condition.
The 0 and 150 µA currents were administered in a counterbalanced fashion across the
multiple reinstatement test days.

Immunohistochemistry. For the IHC experiments, a separate cohort of rats were
implanted with electrodes in the infralimbic mPFC and underwent cocaine selfadministration and extinction as described above. Immediately prior to the reinstatement
testing, rats randomly received either 0 or 150 µA current stimulation followed a systemic
priming injection of saline or cocaine (10 mg/kg, i.p.). Rats were placed immediately into
the operant chambers and responding was recorded for 30 min. Rats were then returned
to their home cage for 30 min, since zif expression is known to peak ~60 min following a
stimulus (Wang, 1998). Rats were then deeply anesthetized with sodium pentobarbital
(100 mg/kg) and perfused with 120 mL of ice-cold PBS followed by 60 mL of ice-cold 4%
paraformaldehyde (PFA). The brains were subsequently removed and stored in 4% PFA
for 24 h, at which point the brains were switched to a 30% sucrose solution in PBS for 72
h. Coronal sections (30 µm) were taken using a vibratome in 1% Na azide in PBS and
then processed for immunohistochemistry. Zif immunoreactivity was detected using a
rabbit polyclonal antibody (SantaCruz sc-189, 1:1000). Coronal sections were mounted
on electrostatic slides (both conditions, stimulated and not stimulated, were mounted on
the same slide) and allowed to dry. They were then washed with PBS and blocked for 1
h in PBS with 0.1% Triton X-100 and 3% normal donkey serum. Following the blocking
step, slides were incubated overnight in primary antibody, 0.1% Triton X-100, and 3%
normal donkey serum at 4°C. The following day, the slides were washed in PBS and
incubated for 2 h at room temperature in a fluorescent secondary antibody (AlexaFluor
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488 anti-rabbit, 1:500) and 3% normal donkey serum. The slides were washed for a final
time, allowed to air dry, and coverslipped using DPX mountant. Staining was visualized
with a confocal microscope.

Verification of electrode placements. After the completion of all experiments, the animals
were given an overdose of pentobarbital (100 mg/kg) and perfused intracardially with
0.9% saline followed by 10% formalin. The brains were removed and coronal sections
(100 µm) were taken with a vibratome (Technical Products International; St. Louis, MO,
USA). Animals with electrode placements outside of the areas of interest, or with
excessive mechanical damage, were excluded from subsequent data analysis.

Drugs. Cocaine hydrochloride was obtained from the National Institute on Drug Abuse
(Rockville, MD, USA) and dissolved in bacteriostatic 0.9% saline.

Statistics. All reinstatement experiments were analyzed with two-way ANOVAs with
repeated measures over reinstatement days. Pairwise analyses were made with
Bonferroni post-tests (p < 0.05).
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Results
Deep brain stimulation of the infralimbic, but not prelimbic or anterior cingulate,
prefrontal cortex attenuates cocaine reinstatement
The mPFC has been shown to be critically involved in the reinstatement of cocaine
seeking (McFarland and Kalivas, 2001; Park et al., 2002; Stefanik et al., 2013).
However, the effect of mPFC DBS on cocaine seeking has not yet been examined. Total
active and inactive lever responding (mean±SEM) from the reinstatement session during
which DBS was applied to the infralimbic mPFC are presented in Figure 1A. These data
were analyzed using a two-way ANOVA (both treatment and lever were within-subject
factors), which revealed no effect of DBS treatment (F(1,7) = 2.52, p=0.16), a significant
main effect of lever responding (F(1,7) = 36.91, p<0.001), and a significant interaction
between these variables (F(1,7) = 7.849, p<0.05). Subsequent pairwise analyses
indicated that the total active lever responses between the 0 and 150 µA treatment were
significantly different (Bonferroni, p<0.05).

In order to determine if the effects of DBS in the infralimbic mPFC were reinforcerspecific, we tested its effects on sucrose reinstatement. Total active and inactive lever
responding (mean±SEM) from the reinstatement session during which DBS was applied
to the infralimbic mPFC are presented in Figure 1B. These data were analyzed using a
two-way ANOVA which revealed no effect of DBS treatment (F(1,8) = 0.2339, p=0.64), a
significant main effect of lever responding (F(1,8) = 70.74, p<0.0001), and no interaction
between these variables (F(1,8) = 0.4386, p=0.53). The electrode placements for both
cocaine and sucrose experiments are shown in Figure 1C.
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Total active and inactive lever responding (mean±SEM) from the reinstatement session
during which DBS was applied to the prelimbic and anterior cingulate cortices are
presented in Figure 2A and 2B, respectively. These data were analyzed using separate
two-way ANOVAs. The results of the prelimbic mPFC (Fig 2A) revealed no effect of DBS
treatment (F(1,7) = 1.779, p=0.22), a significant main effect of lever responding (F(1,7) =
35.09, p<0.001), and no interaction between these variables (F(1,7) = 0.7098, p=0.43).
The results of the anterior cingulate mPFC (Fig 2B) revealed no effect of DBS treatment
(F(1,6) = 1.099, p=0.34), a significant main effect of lever responding (F(1,6) = 34.15,
p<0.01), and no interaction between these variables (F(1,6) = 1.874, p=0.22). Subsequent
pairwise analyses indicated that the total inactive lever responses between the 0 and
150 µA treatment were significantly different (Bonferroni, p<0.05). The electrode
placements for both regions are shown in Figure 2C.

Deep brain stimulation of the basolateral amygdala attenuates the reinstatement of both
cocaine and sucrose seeking
There is strong evidence for the BLA in the reinstatement of cocaine seeking, as lesions
of the BLA attenuated cocaine priming-induced reinstatement (Yun and Fields, 2003).
Additionally, optogenetic inhibition of the BLA attenuated cocaine reinstatement
(Stefanik and Kalivas, 2013).

Total active and inactive lever responding (mean±SEM) from the reinstatement session
during which DBS was applied to the BLA are presented in Figure 3A. These data were
analyzed using a two-way ANOVA which revealed a strong trend of DBS treatment (F(1,6)
= 5.171, p=0.06), a significant main effect of lever responding (F(1,6) = 88.07, p<0.0001),
and a significant interaction between these variables (F(1,6) = 7.76, p<0.05). Subsequent
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pairwise analyses indicated that the total active lever responses between the 0 and 150
µA treatment were significantly different (Bonferroni, p<0.05).

To determine if the effects of DBS in the BLA were reinforcer-specific, we tested its
effects on sucrose reinstatement. Total active and inactive lever responding
(mean±SEM) from the reinstatement session during which DBS was applied to the BLA
are presented in Figure 3B. These data were analyzed using a two-way ANOVA which
revealed a significant main effect of DBS treatment (F(1,5) = 10.86, p<0.05), a significant
main effect of lever responding (F(1,5) = 28.69, p<0.01), and a significant interaction
between these variables (F(1,5) = 26.31, p<0.01). Subsequent pairwise analyses
indicated that the total active lever responses between the 0 and 150 µA treatment were
significantly different (Bonferroni, p<0.05). The electrode placements are shown in
Figure 3C.

Deep brain stimulation of the ventral hippocampus attenuates the reinstatement of both
cocaine and sucrose seeking
The ventral hippocampus has been shown to be critical nucleus in promoting cocaine
reinstatement. Inactivation of the ventral hippocampus with lidocaine blocked cocaine
priming-induced reinstatement (Sun and Rebec, 2003). Consistent with this,
administration of baclofen and muscimol to the ventral hippocampus attenuated cocaine
priming-induced reinstatement (Rogers and See, 2007).

Following cocaine self-administration and extinction, DBS of the ventral hippocampus (0
or 150 µA) was administered throughout a 2 h cocaine-primed reinstatement session.
Total active and inactive lever responding (mean±SEM) from the reinstatement session
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during which DBS was applied to the ventral hippocampus are presented in Figure 4A.
These data were analyzed using a two-way ANOVA which revealed a significant effect
of DBS treatment (F(1,5) = 9.453, p<0.05), a significant main effect of lever responding
(F(1,5) = 8.092, p<0.05), and a significant interaction between these variables (F(1,5) =
12.83, p<0.05). Subsequent pairwise analyses indicated that the total active lever
responses between the 0 and 150 µA treatment were significantly different (Bonferroni,
p<0.05).

In order to determine if the effects of DBS in the ventral hippocampus were reinforcerspecific, we tested its effects on sucrose reinstatement. Total active and inactive lever
responding (mean±SEM) from the reinstatement session during which DBS was applied
to the ventral hippocampus are presented in Figure 4B. These data were analyzed using
a two-way ANOVA which revealed no effect of DBS treatment (F(1,7) = 3.507, p=0.1033),
lever responding (F(1,7) = 23.45, p=0.0019), and a significant interaction between these
variables (F(1,7) = 7.314, p=0.0304). Subsequent pairwise analyses indicated that the
total active lever responses between the 0 and 150 µA treatment were significantly
different (Bonferroni, p<0.05). The electrode placements are shown in Figure 4C.

Deep brain stimulation of the infralimbic medial prefrontal cortex reduced neuronal
activation in the nucleus accumbens shell
It has been demonstrated that disruption of cortico-accumbal glutamatergic projections
attenuates cocaine seeking (Park et al., 2002; Schmidt and Pierce, 2010). To determine
if infralimbic mPFC DBS attenuated activation of glutamatergic projection neurons in the
nucleus accumbens shell during cocaine reinstatement, we used immunohistochemistry
to determine the levels of the immediate-early gene zif268 following DBS. Briefly, rats
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underwent cocaine self-administration and extinction as described previously.
Subsequently, rats underwent a 30 min reinstatement session and randomly received 0
or 150 µA stimulation following a systemic priming challenge injection of either saline or
cocaine (10 mg/kg, i.p.).

Total active lever responses (mean ± SEM) from the 30 min reinstatement session are
shown in Figure 5A. These data were analyzed using a two-way ANOVA (both DBS
treatment and challenge were between-subject factors), which revealed significant main
effects of DBS treatment (F(1,4) = 16.32, p<0.05), challenge injection (F(1,4) = 33.94,
p<0.01), and a significant interaction between these variables (F(1,4) = 15.64, p<0.05).
Post hoc analyses showed that total active lever responses were significantly different
between Cocaine/Control groups and all other groups (Bonferroni, p<0.05)

Total zif268-positive cells (mean ± SEM) in the nucleus accumbens shell are quantified
and shown in Figure 5B. These data were analyzed using a two-way ANOVA, which
revealed significant main effects of DBS treatment (F(1,4) = 64.57, p<0.01), challenge
injection (F(1,4) = 62.16, p<0.01), and a significant interaction between these variables
(F(1,4) = 64.57, p<0.01). Post hoc analyses showed that the amount zif268-positive cells
were significantly different between Cocaine/Control groups and all other groups
(Bonferroni, p<0.01; n = 2/group). Representative images of zif268 staining are shown in
Figure 5C.
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Discussion
The mPFC, vHipp, and BLA send rich glutamatergic projections to the nucleus
accumbens (Phillipson and Griffiths, 1985; Friedman et al., 2002) and are critical for the
reinstatement of cocaine seeking (Grimm, 2000; McFarland and Kalivas, 2001; Sun and
Rebec, 2003; Schmidt and Pierce, 2010; Lüscher and Malenka, 2011). In this study, we
examine whether these nuclei could also serve as target regions for DBS in the
treatment of cocaine addiction. The present results show that DBS of the infralimbic
mPFC attenuates the reinstatement of cocaine, but not sucrose, seeking. Further, we
show that this effect is region-specific as DBS in the prelimbic mPFC or anterior
cingulate cortex does not attenuate cocaine reinstatement. We also show that DBS of
the BLA or the vHipp attenuates the reinstatement of both cocaine and sucrose seeking,
illustrating possible deficits in natural reward processing and operant responding.
Collectively, these results provide evidence that the infralimbic mPFC may be an
effective target for DBS in the treatment of intractable drug addiction.

The mPFC can be divided into three functional subregions: the anterior cingulate cortex,
the prelimbic cortex, and the infralimbic cortex (Krettek and Price, 1977). Our findings
indicate that DBS of the infralimbic mPFC, but not the prelimbic or anterior cingulate
cortices, attenuates cocaine reinstatement. Further, we observe an increase in inactive
lever responding when DBS is applied to the anterior cingulate cortex, suggesting a
generalized disruption in locomotor behavior. Since DBS of the infralimbic mPFC
selectively attenuates cocaine, but not sucrose reinstatement, and we see no effect on
cocaine reinstatement and generalized disruption in locomotor behavior when DBS is
applied to the prelimbic and anterior cingulate cortices, this suggests that the infralimbic
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mPFC is the ideal mPFC subregion to target when applying DBS for the treatment of
cocaine addiction.

Our findings add to the complex literature surrounding the role of infralimbic-accumbens
shell projections in the reinstatement of cocaine seeking. The mPFC subregions have
differential glutamatergic projections to the nucleus accumbens. The dorsal mPFC (i.e.
anterior cingulate and dorsal prelimbic cortices) projects mainly to the nucleus
accumbens core, whereas the ventral mPFC (i.e. ventral prelimbic and infralimbic
cortices) projects primarily to the nucleus accumbens shell (Berendse et al., 1992;
Wright and Groenewegen, 1995; Ding et al., 2001). The present results are consistent
with previous work showing that DBS of the accumbens shell, but not the core,
attenuates the reinstatement of cocaine seeking (Vassoler et al., 2013). However, these
findings appear at odds with other studies showing that administration of a cocktail of
GABA receptor agonists baclofen and muscimol into the core, but not the shell, as well
as all 3 subregions of the mPFC attenuates cocaine reinstatement (Vassoler et al.,
2013). Moreover, administration of baclofen and muscimol into the infralimbic mPFC
reinstates cocaine seeking while microinjections of AMPA into this region attenuates
cocaine seeking (Peters et al., 2008). Since multiple neurotransmitter systems in the
mPFC are involved in cocaine reinstatement, these conflicting findings emphasize that a
single pharmacological manipulation cannot provide definitive conclusions about the role
of a single brain region in cocaine reinstatement. Additionally, our results may differ from
these pharmacological studies as DBS has multiple potential mechanisms including, but
not limited to, inactivation of target nuclei. Though there are wide-ranging findings
suggesting that the infralimbic mPFC plays a complex role in drug-seeking behavior
(Moorman et al., 2015), the present results add to the growing body of literature
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demonstrating a role for infralimbic mPFC-accumbens shell glutamatergic pathway in the
reinstatement of drug seeking (Bossert et al., 2012; Vassoler et al., 2013; Willcocks and
McNally, 2013).

In this study, we show that DBS of the BLA attenuates the reinstatement of both cocaine
and sucrose seeking. The amygdala can be divided into many subnuclei, several of
which play an important role in drug-seeking behavior, particularly cue-induced
reinstatement of cocaine seeking (Grimm, 2000; McFarland et al., 2004; Fuchs et al.,
2005; Mashhoon et al., 2009; Stefanik and Kalivas, 2013). The BLA is also implicated in
drug priming-induced reinstatement of cocaine seeking. Lesions of the BLA attenuates
cocaine priming-induced reinstatement (Yun and Fields, 2003). Further, antagonism of
D1-like and D2-like dopamine receptors, in the BLA attenuates cocaine priming-induced
reinstatement (Alleweireldt et al., 2006; Di Ciano, 2008). In addition to reducing drugseeking behavior, our results also show that DBS of the BLA also attenuates sucrose
reinstatement. This is consistent with data suggesting that the BLA plays a complex role
in reward-related behaviors. Specifically, lesions of the BLA block conditioned place
preference for food (Everitt et al., 1991) as well as impair approach to a conditioned
stimulus predictive of sucrose reinforcement (Burns et al., 1993). Other findings show
that inactivation of the BLA has no effect on, or even potentiates reinstatement of food
seeking (McLaughlin and Floresco, 2007). Further, neurons in the BLA exhibit complex
response properties depending on behavioral tasks and outcomes (Carelli et al., 2003;
Tye et al., 2008; 2010). Since DBS of the BLA indiscriminately impairs operant
responding, these findings suggest that it may not be an effective target for DBS in the
treatment of cocaine addiction.
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Similar to DBS in the BLA, DBS of the vHipp also attenuates both cocaine and sucrose
reinstatement. The hippocampus, a critical region for memory and reward-related
behaviors, can be segregated into dorsal and ventral regions (Moser and Moser, 1998).
The dorsal hippocampus is critical for spatial memory (Moser et al., 1995), whereas the
ventral hippocampus plays more important role in motivated behaviors (Henke, 1990).
Like the mPFC and BLA, the vHipp is strongly innervated with dopaminergic projections
from the VTA (Gasbarri et al., 1994a; 1994b). Additionally, the vHipp is the major output
region of the hippocampus (Groenewegen et al., 1987), with strong projections to the
nucleus accumbens, particularly the accumbens shell (Fanselow and Dong, 2010).
There is evidence for the role of the vHipp in the reinstatement of cocaine seeking.
Inactivation of the vHipp with lidocaine blocks cocaine priming-induced reinstatement
(Sun and Rebec, 2003). Consistent with this, administration of baclofen and muscimol to
the vHipp attenuates cocaine priming-induced reinstatement (Rogers and See, 2007).
However, there is also evidence that modulation of the vHipp can affect other rewardrelated behaviors. Specifically, stimulation of ghrelin receptors in the vHipp increases ad
libitum food taking and operant responding for food reward (Kanoski et al., 2013).
Additionally, stimulation of glucagon-like peptide-1 (GLP-1) receptors in the vHipp
attenuates both ad libitum food taking and operant responding for food reward (Hsu et
al., 2015). These findings support the literature showing that disrupting activity in the
vHipp can impair natural reward processing. For these reasons, the vHipp may not be an
appropriate target for DBS in the treatment of cocaine addiction.

We also demonstrate that infralimbic mPFC DBS reduces zif268 immunoreactivity in the
nucleus accumbens shell, suggesting that the reduction in cocaine seeking is likely
mediated by inactivation of glutamatergic projection neurons. This is in agreement with
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our previous work showing that DBS of the accumbens shell is associated with
antidromic activation of GABAergic interneurons in the infralimbic mPFC (Vassoler et al.,
2013). Moreover, accumbal DBS inhibits spontaneous activity of prefrontal corticoaccumbal glutamatergic neurons while also stimulating cortical interneurons (McCracken
and Grace, 2007). Taken together, these findings suggest that accumbal DBS impairs
glutamatergic transmission from the mPFC. Our results expand upon this finding and
suggest that infralimbic mPFC DBS attenuates glutamatergic transmission in the
accumbens shell to reduce cocaine seeking. This suggests that DBS produces
inactivation in the target nucleus, rather than antidromic activation of afferent structures.
This is consonant with similar findings in depression showing that DBS in these regions
produces similar behavioral outcomes, albeit with distinct patterns of regional activity
and functional connectivity (Hamani et al., 2014).

The current findings contribute to the growing body of literature indicating that DBS may
be an effective therapeutic intervention in the treatment of cocaine addiction. Moreover,
these data support previous claims that the mPFC may be a potentially effective target
for DBS in the treatment of addiction (Luigjes et al., 2012). Our preclinical findings
strongly suggest that in addition to the nucleus accumbens shell (Vassoler et al., 2008;
2013), the infralimbic mPFC may be another effective target for DBS (present results).
Our results also indicate that when considering brain regions to target for DBS as a
treatment for cocaine craving, one must take into account the potential of DBS to
produce adverse effects on behavior, including general motor impairments, deficits in
operant learning, and altered natural reward processing. Further studies should examine
in greater detail the circuit-wide influences of both infralimbic mPFC and accumbal shell
DBS in cocaine reinstatement in order to optimize their therapeutic strategy.
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Figure 3. 1 Deep brain stimulation of the infralimbic mPFC attenuates cocaine reinstatement. (A)
Mean (±SEM) active and inactive lever responses from cocaine reinstatement session with 0 or
150 µA stimulation aimed at the infralimbic mPFC. (B) Mean (±SEM) active and inactive lever
responses from sucrose reinstatement session with 0 or 150 µA stimulation aimed at the
infralimbic mPFC. (C) Electrode placements from the infralimbic mPFC (dark circles). The values
are in millimeters, relative to bregma. *p < 0.05 0 µA compared to 150 µA. There were 8-9
animals per group.
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Figure 3. 2 Deep brain stimulation of the prelimbic or anterior cingulate cortices has no effect on
cocaine reinstatement. (A) Mean (±SEM) active and inactive lever responses from cocaine
reinstatement session with 0 or 150 µA stimulation aimed at the prelimbic mPFC. (B) Mean
(±SEM) active and inactive lever responses from cocaine reinstatement session with 0 or 150 µA
stimulation aimed at the anterior cingulate cortex. (C) Electrode placements from the prelimbic
mPFC (dark circles) and anterior cingulate cortex (grey circles). The values are in millimeters,
relative to bregma. *p < 0.05 0 µA compared to 150 µA. There were 7-8 animals per group.
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Figure 3. 3 Deep brain stimulation of the basolateral amygdala attenuates both cocaine and
sucrose reinstatement. (A) Mean (±SEM) active and inactive lever responses from cocaine
reinstatement session with 0 or 150 µA stimulation aimed at the BLA. (B) Mean (±SEM) active
and inactive lever responses from sucrose reinstatement session with 0 or 150 µA stimulation
aimed at the BLA. (C) Electrode placements from the BLA (dark circles). The values are in
millimeters, relative to bregma. *p < 0.05 0 µA compared to 150 µA. There were 7 animals per
group.
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Figure 3. 4 Deep brain stimulation of the ventral hippocampus attenuates both cocaine and
sucrose reinstatement. (A) Mean (±SEM) active and inactive lever responses from cocaine
reinstatement session with 0 or 150 µA stimulation aimed at the vHipp. (B) Mean (±SEM) active
and inactive lever responses from sucrose reinstatement session with 0 or 150 µA stimulation
aimed at the vHipp. (C) Electrode placements from the BLA (dark circles). The values are in
millimeters, relative to bregma. *p < 0.05 0 µA compared to 150 µA. There were 6-8 animals per
group.
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Figure 3. 5 Deep brain stimulation of the infralimbic mPFC is associated with decreased zif268
immunoreactivity in the nucleus accumbens shell. At the reinstatement test session, all animals
received either a saline or cocaine priming injection followed by either 0 or 150 µA stimulation. (A)
Mean (±SEM) active and inactive lever responses from 30 min reinstatement session. (B) Mean
(±SEM) zif268-positive cells in the nucleus accumbens shell. (C) Representative images from all
conditions. *p < 0.05 0 µA compared to 150 µA. There were 2 animals per group.
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Abstract
There is a large body of evidence suggesting that many of the cellular and molecular
mechanisms that underlie learning and memory are also critically involved in cocaineinduced plasticity. A-Kinase Anchoring Proteins (AKAPs) are scaffolding proteins that
localize Protein Kinase A (PKA) to subcellular compartments to facilitate second
messenger signaling. Though there are many different isoforms of AKAPs, AKAP150 is
the most well-characterized and is highly expressed in the brain. Though the role of
AKAP150 in synaptic plasticity, learning, and memory has been well established, its
involvement in cocaine addiction has been minimally explored. Here, we examine the
role of AKAP150 in the reinstatement of cocaine-seeking behavior, an animal model of
relapse. The present results show that blockade of PKA binding to AKAPs in the nucleus
accumbens shell of Sprague-Dawley rats attenuates cocaine reinstatement induced by a
both priming injection of cocaine and intra-accumbal shell administration of a D1-like
dopamine receptor (D1DR) agonist. Moreover, this effect seems to be dependent on the
AKAP150 isoform as viral expression of a dominant negative isoform of AKAP150
lacking the PKA binding domain in the accumbens shell also attenuates cocaine
reinstatement. This attenuation in cocaine reinstatement is accompanied by decreased
phosphorylation of GluA1-containing AMPA receptors (AMPARs). Additionally, our
findings also reveal decreases in AMPAR eEPSCs after disruption of PKA binding to
AKAP150. Collectively, these results support the novel hypothesis that AKAP150
promotes the reinstatement of cocaine-seeking behavior by facilitating D1DR-induced,
PKA-mediated phosphorylation of GluA1-containing AMPARs.
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Introduction
Neuroadaptations in both the dopamine and glutamate systems in the nucleus
accumbens contribute heavily to the reinstatement of cocaine seeking, an animal model
of relapse (Shaham and Hope, 2005; Kauer and Malenka, 2007; Schmidt and Pierce,
2010). It has been shown that stimulation of accumbens shell, but not core, D1-like
dopamine receptors (D1DRs) promoted the reinstatement of cocaine seeking (Bachtell
et al., 2005; Schmidt et al., 2006; Anderson et al., 2008). Additionally, administration of a
D1DR antagonist into the accumbens shell, but not the core, attenuated cocaine
reinstatement (Anderson et al., 2003; Bachtell et al., 2005). D1DR stimulation leads to
increased cyclic adenosine monophosphate (cAMP) production, ultimately activating
protein kinase A (PKA) (MISSALE et al., 1998; Beaulieu and Gainetdinov, 2011).
Chronic exposure to cocaine leads to increased D1DR signaling, as well as increased
cAMP formation and PKA activity in the nucleus accumbens (Self et al., 1995; Unterwald
et al., 1996; Lu et al., 2003), which have been implicated in cocaine self-administration
and reinstatement (Self et al., 1998).

One of the intracellular targets of PKA is the AMPA glutamate receptor (AMPAR), which
plays a major role in cocaine reinstatement (Schmidt and Pierce, 2010). PKA
phosphorylation of the GluA1 subunit of AMPARs leads to increased open probability of
AMPARs as well as increased surface expression of GluA1-containing AMPARs (Banke
et al., 2000; Malinow, 2003). In cultured accumbal neurons, D1DR stimulation increased
both GluA1 phosphorylation by PKA and GluA1 surface expression (Chao et al., 2002a;
2002b). Moreover, cocaine reinstatement was attenuated by intra-accumbal shell
administration of AAV10-GluA1-C99, which impairs the trafficking of GluA1-containing
AMPARs to the cell surface (Anderson et al., 2008). Thus, one of the main mechanisms
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underlying cocaine priming-induced reinstatement of drug seeking is the activation of
D1DRs in the accumbens shell, which results in PKA-dependent insertion of GluA1containing AMPARs into synapses.

A-Kinase anchoring proteins (AKAPs) are a family of proteins that bind and localize PKA
to distinct subcellular compartments to facilitate second messenger signaling (Wong and
Scott, 2004; Carnegie et al., 2009). While there are many different forms of AKAPs,
AKAP79/150 (human79/rodent150; also known as AKAP5) is the best characterized
(Wong and Scott, 2004). AKAP150 is highly expressed in the brain, particularly the
striatum/accumbens, and binds numerous signaling, receptor, accessory, and ion
channel proteins involved in long-term synaptic plasticity (Glantz et al., 1992;
Ostroveanu et al., 2007; Sanderson and Dell'Acqua, 2011). In particular, AKAP150
localizes PKA to AMPARs via interaction with the scaffolding protein SAP97, leading to
enhanced phosphorylation of GluA1 (Colledge et al., 2000; Tavalin et al., 2002). This
process was shown to be critical in mediating synaptic plasticity and memory formation.
Thus, either total deletion or deletion of the final 36 amino acids of AKAP150, which
contains the PKA binding domain, impaired operant learning, spatial memory,
hippocampal LTP and LTD, and reduced AMPA currents (Tunquist et al., 2008;
Weisenhaus et al., 2010). Additionally, sleep deprived mice exhibiting memory deficits
showed reduced AKAP150 expression and reduced AMPAR phosphorylation
(Hagewoud et al., 2009). Recent evidence also indicated that AKAP150 expression was
increased in the post-synaptic density PSD fractions of the nucleus accumbens of
cocaine-treated rats and disruption of AKAP-PKA binding attenuated cocaine
reinstatement (Reissner et al., 2011). These findings strongly suggest a potential role for
AKAP150 in mediating cocaine addiction and craving.
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In the current study, we further investigated the role of AKAP150 in the reinstatement of
cocaine seeking. Using biochemical and electrophysiological techniques, we examined
the underlying signaling mechanisms by which AKAP150 can affect cocaine
reinstatement. Our results demonstrate that AKAP150 facilitates cocaine reinstatement
by promoting the D1DR-induced, PKA-mediated phosphorylation of GluA1-containing
AMPARs.
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Materials and Methods
Animals and housing: Male Sprague-Dawley rats (Rattus norvegicus) weighing 250-300
g were obtained from Taconic Laboratories (Germantown, NY). Rats were housed
individually with food and water available ad libitum. A 12/12 hr light/dark cycle was used
with the lights on at 7:00 a.m. All experimental procedures were performed during the
light cycle. All experimental procedures were consistent with the ethical guidelines of the
US National Institutes of Health and were approved by the Perelman School of Medicine
Institutional Animal Care and Use Committee at the University of Pennsylvania.

Materials: All experiments used Med-Associates (East Fairfield, VT) instrumentation
enclosed within ventilated, sound attenuating chambers. Each operant conditioning
chamber was equipped with response levers, food pellet dispensers and infusion pumps
for injecting drugs intravenously.

Drugs and Viruses. Cocaine hydrochloride was obtained from the National Institute on
Drug Abuse (Rockville, MD) and dissolved in bacteriostatic 0.9% saline. InCELLect
AKAP inhibitor St-Ht31 and control peptide St-Ht31P were purchased from Promega
(Madison, WI). D1-like dopamine receptor agonist R-(+)-6-chloro-7,8-dihydroxy-1phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF-81297) was purchased
from Tocris Bioscience (Minneapolis, MN). SKF-81297 was dissolved in bacteriostatic
0.9% saline.

Herpes simplex virus (HSV) vectors were constructed and packaged at the Viral Gene
Transfer Core at the McGovern Institute for Brain Research (MIT, Cambridge, MA, USA)
as described previously (Neve et al., 2005). Briefly, AKAP79∆PKA cDNA was inserted
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into the HSV amplicon HSV-PrpUC, packaged and resuspended in 10% sucrose. The
8

average titer of the resulting HSV stocks was 4.0 x 10 infectious units per ml.
Transgene expression was regulated by HSV IE 4/5 vectors, which produced a transient
increase in transgene expression that was maximal between 3 and 4 days after infusion
and dissipated completely by 6–7 days (Neve et al., 2005). All viruses were designed to
co-express enhanced green fluorescent protein (eGFP) driven by a separate CMV
promoter. Control viruses express a scrambled sequence plus eGFP. Control virus
expressed an empty vector plus eGFP.

Surgery: Prior to surgery, the rats were anesthetized with 80 mg/kg ketamine and 12
mg/kg xylazine. An indwelling silastic catheter was placed into the right jugular vein
(side opposite the heart) and sutured in place. The catheter was then threaded
subcutaneously over the shoulder blade and was routed to a mesh backmount platform
(CamCaths, Cambridge, UK/ Strategic Applications Inc., Libertyville, Il) that was sutured
below the skin between the shoulder blades. Catheters were flushed daily with 0.3 ml of
an antibiotic (Timentin, 0.93 mg/ml) dissolved in heparinized saline. The catheters were
sealed with plastic obturators when not in use. Following catheter implantation, rats were
mounted in a stereotaxic apparatus (Kopf Instruments, CA) and stainless steel guide
cannula (14 mm, 24 gauge; Small Parts Inc., Roanoke, VA) were implanted dorsal to the
nucleus accumbens shell according to the following coordinates, relative to bregma
(Paxinos and Watson, 1997): +1.0 mm anteroposterior (A/P), ±1.0 mm mediolateral
(M/L), -5.0 mm dorsoventral (D/V). Guide cannulae were cemented in place by affixing
dental acrylic to three stainless steel screws fastened to the skull. An obturator (33gauge wire) was inserted into each guide cannula to prevent occlusion.
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Cocaine self-administration and extinction. Following a 7 d period for recovery from
surgery, rats were placed in operant conditioning chambers and allowed to press a lever
for intravenous cocaine infusions (0.254 mg of cocaine, 59 µL of saline, infusion over 5
s). Rats initially were trained using a fixed ratio 1 (FR1) schedule of reinforcement. When
the animals achieved stable responding with the FR1 schedule (i.e., <15% variation in
total presses over 3 consecutive days), they were switched to an FR5 schedule. A 20 s
timeout period during which active, drug-paired lever responses had no scheduled
consequences followed each cocaine infusion. Each operant chamber was also
equipped with an inactive lever. Responses made on the inactive lever had no
scheduled consequences and served as an operant control. The rats were limited to a
maximum of 30 cocaine infusions per daily 2 h self-administration session. After 21 d of
daily cocaine self-administration sessions, rats underwent an extinction phase during
which cocaine was replaced with 0.9% bacteriostatic saline. Daily 2 h extinction sessions
were conducted until active lever responding was <15% of the responses averaged over
the last 3 days of cocaine self-administration.

Sucrose self-administration and extinction. Following a 7 d period for recovery from
surgery, a separate group of rats were food restricted (~25 g of daily chow; Harland
Teklad, Wilmington, DE) and allowed to self-administer 50 mg Noyes sucrose pellets
(Research Diets; New Brunswick, NJ, USA) using the same procedures described
above. After 21 d of daily 1 h sucrose-reinforced operant sessions, rats underwent an
extinction phase where active lever responding no longer resulted in sucrose delivery.
Extinction of sucrose self-administration was continued until active lever responding
decreased to 15% or less of the responses averaged over the last 3 days of sucrose
self-administration.
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Cocaine and Sucrose Reinstatement – St-Ht31 Microinjections. Following the extinction
phase, reinstatement was assessed. The obturators were removed from the guide
cannulae and 33-gauge stainless steel microinjectors were inserted into the guide
cannulae. The microinjectors extended 2 mm below the ventral end of the guide
cannulae into the nucleus accumbens shell. To determine the role of AKAP signaling in
cocaine reinstatement, bilateral intra-accumbal shell microinfusions of St-Ht31 or control
St-Ht31P peptide (0.5 µL, 10mM) occurred over 120 s. This dose of St-Ht31 was
previously shown to modulate cocaine-seeking behavior (Reissner et al., 2011).
Following microinfusions, the microinjectors remained in place for an additional 60 s to
allow the solution to diffuse away from the tips of the microinjectors prior to removal. For
cocaine reinstatement, 30 min following intra-accumbal shell microinjections, a systemic
priming injection of cocaine (10mg/kg, i.p.) was administered immediately prior to a
reinstatement test session. During reinstatement, satisfaction of the response
requirements for each component resulted in a saline infusion rather than a cocaine
infusion. For sucrose reinstatement, the experimenter remotely administered one
sucrose pellet every 2 min for the first 10 min of the reinstatement test session.
For sucrose reinstatement, active lever presses had no scheduled consequences. For
both cocaine and sucrose reinstatement, each reinstatement session was followed by
extinction sessions (typically only one or two) until responding was <15% of the
response rate maintained by self-administration. The FR5 schedule was used
throughout extinction and reinstatement. St-Ht31 or St-Ht31P were administered in the
reinstatement session in a counterbalanced fashion.

In a separate experiment, cocaine reinstatement was induced by intra-accumbal shell
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microinfusions of the selective D1-like dopamine receptor (D1DR) agonist SKF-81297 as
described previously (Schmidt et al., 2006). To determine whether AKAPs mediate
D1DR agonist-induced reinstatement of cocaine seeking, St-Ht31 or control St-Ht31P
(0.5 µL, 10mM) was microinjected into the shell 30 min before intra-accumbal shell
infusions of SKF-81297 (0.5 µL).

Cocaine and Sucrose Reinstatement – Viral Vectors. In these experiments, rats
underwent daily extinction sessions until active lever responding was ~20% of the
responses averaged over the final 3 d of self-administration. Rats then received bilateral
intra-accumbal shell microinfusions of either HSV-GFP or HSV-AKAP79∆PKA over 10
min for a total volume of 2 µL per hemisphere. Following the microinfusions, the
microinjectors were left in place for an additional 120 s to allow the solution to diffuse
away from the tips. Rats continued to undergo extinction for 3 days for peak viral
expression prior to reinstatement testing. Cocaine and sucrose reinstatement were
induced as described above.

Western Blotting. Rats underwent cocaine reinstatement with viral pretreatments as
described above. Immediately prior to the reinstatement testing, animals randomly
received a systemic priming injection of saline or cocaine (10 mg/kg, i.p.). Rats were
placed immediately into the operant chambers following injection of saline or cocaine.
Responding was recorded for 30 min, after which the pairs of rats were removed from
the operant chambers and immediately decapitated. Whole brains were extracted and
flash-frozen in isopentane on dry ice, then stored at -80◦C. Brains were sliced on a
cryostat and the nucleus accumbens shell was dissected by tissue punch (2.0 mm Harris
Unicore stainless steel punchers, Ted Pella, Inc.). Tissue samples were stored at −80◦C
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until processing for Western bloting. Tissue was processed for Western Blotting as
described previously (Anderson et al., 2008). For all samples, protein concentration was
quantified using a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Equal
amounts of protein (10–20µg) were loaded and separated in 10% Tris-Glycine gels (Life
Technologies, Grand Island, NY) by SDS-PAGE, then transferred to nitrocellulose
membranes using the iBlot dry transfer system (Life Technologies), which were then
preblocked with Tris-buffered saline containing 0.1% Tween 20 (TBST) and 5% bovine
serum albumin for 1 h before overnight incubation with the following primary antibodies:
pSer845-GluA1 (1:1000, Millipore #04-1073), total GluA1 (1:1000, Millipore #MAB2263),
PKA-RII (1:1000, Santa Cruz #sc-909). Membranes were concurrently incubated with
mouse monoclonal anti-GAPDH (1:2000, Cell Signaling #2118) as a loading control.
Primary antibody incubation was followed by three washes [10 min each with rocking,
room temperature (RT)] in Tris-buffered saline containing 0.1% Tween 20. Membranes
were then incubated for 1 h at RT with secondary antibodies (IRDye 800 goat antimouse and IRDye 680 goat anti-rabbit, 1:5000) in Odyssey blocking buffer 0.05% Tween
20 (LI-COR Biosciences). Antibody/protein complexes were visualized using the
Odyssey IR imaging system (Li-Cor Biosciences). For pSer845 and GluA1 analysis, gels
were transferred to nitrocellulose membranes for 1 hour at 100V using SDS Running
Buffer (Bio-Rad) and immunoprobed in TBST with 5% milk (Bio-Rad). HRP conjugated
secondary antibody dilutions were 1:10,000 (Bio-Rad). Bands were visualized using the
myECL Imager (ThermoFisher Scientific). Band intensities were quantified using either
the Odyssey or mECL Imaging software. For data analysis, all bands were normalized to
GAPDH and divided by the mean of the control group. The ratio of phosphorylated to
native protein was then calculated.
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Electrophysiology. A separate cohort of rats underwent cocaine reinstatement with viral
pretreatments as described above. Immediately after a 30 min reinstatement session,
rats were decapitated and brain slices prepared as described previously (Ortinski et al.,
2013). In brief, the brain was removed and coronal slices (300 µm) containing the
nucleus accumbens were cut with a Vibratome (VT1000S, Leica Microsystems) in icecold dissection artificial cerebrospinal fluid solution (aCSF), in which NaCl was replaced
by an equiosmolar concentration of sucrose. Dissecting aCSF consisted of 219 mM
sucrose, 2.5 mM KCl, 1.2 mM NaH2PO4, 26 mM NaHCO3, 10 mM glucose, 2.5 mM
MgSO4, and 1 mM CaCl2 (pH 7.2–7.4 when saturated with 95% O2/5% CO2). Slices
were incubated at 32-35°C for 30 min in recording aCSF and then maintained at room
temperature. Recording aCSF consisted of (in mM): 219 NaCl, 2.3 KCl, 1.25 mM
NaH2PO4, 26 NaHCO3, 10 glucose, 1 MgCl2, 2 CaCl2. Prior to experiments, slices were
transferred to a recording chamber continuously perfused with oxygenated aCSF at 1.82 mL/min and heated to 30°C. Slices were viewed using infrared differential interference
contrast optics under an upright microscope (Eclipse FN1, Nikon Instruments) with a
40X water immersion objective. Whole-cell recordings were obtained using borosilicate
glass pipettes filled with intracellular solution containing: 95 mM CsCH3O3S, 55 mM
CsCl, 0.2 mM EGTA, 10 mM HEPES, 1 mM MgCl2, 2 mM Na2-ATP, 0.3 mM Na-GTP, 5
mM QX-314, 0.1mM spermine, adjusted to pH 7.2–7.3 with CsOH (osmolarity 280–290
mOsm). All experiments were performed in the presence of 100 µM picrotoxin (to block
GABAA) and 50 µM APV (to block NMDA). Recordings were conducted with a
MultiClamp 700B, Digidata 1440A, and pClamp software (Molecular Devices) while
acquiring data at 20 kHz and low pass filtered at 2 kHz. Access resistance was
continuously monitored throughout the experiments and cells were discarded if the
access resistance changed by >25%. To avoid recording from damaged cells, neurons
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within 50 µm of the injection cannula track were excluded from the analysis. There were
no differences on any of the measures between GFP- negative cells in slices exposed to
HSV-AKAP79∆PKA and slices exposed to HSV-GFP. Therefore, these cells were
pooled for analysis.
A bipolar tungsten stimulation electrode connected to a stimulus isolator (ISO-Flex) was
typically positioned dorsal to the recorded neuron to trigger evoked EPSCs (eEPSCs).
Stimulation occurred at 0.1 Hz a minimal stimulation intensity required to evoke a
consistent post-synaptic response was determined. Peak eEPSC amplitudes were then
measured at double and triple the minimal stimulation intensity to construct the
input/output curves. Average responses were then calculated based on 5–10 eEPSCs at
each stimulation intensity.

Verification of cannula placements. After the completion of all experiments, rats were
given an overdose of pentobarbital (100 mg/kg, i.p.), brains were removed and stored in
10% formalin for at least 1 week. Coronal sections (100 µm) were taken at the level of
the nucleus accumbens with a vibratome (Technical Products International; St. Louis,
MO, USA). The sections were mounted on gelatin-coated slides. Animals with cannula
placements located outside of the accumbens shell, or with excessive mechanical
damage, were excluded from subsequent data analysis.

Viral expression. To ascertain viral expression, we injected (2 µL/hemisphere) HSVAKAP79∆PKA into the nucleus accumbens shell of separate, drug-naive rats. At 3 days
after injection, animals received 100 mg/kg pentobarbital (i.p.) before perfusion with 120
mL ice-cold PBS followed by 60 mL 4% PFA dissolved in ice-cold PBS. Brains were
removed and placed in 4% PFA for 24 h before storage in 30% sucrose dissolved in
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PBS with 1% sodium azide. Coronal sections (30 µm) were taken using a vibratome
(Technical Products International; St. Louis, MO, USA) and mounted directly onto
polarized glass slides. Dry slides were washed in 1X PBS, and then blocked for 1 h in
0.1% triton and 3% normal donkey serum in 1X PBS. We then added primary antibody
(Anti-GFP, 1:500, Millipore #MAB3580; Anti-AKAP79, 1:500, Santa Cruz #sc-17772) —
diluted 1:1000 in 0.1% triton + 3% donkey serum in PBS to the slides and incubated
overnight at 4°C. The next day, the slides were washed in 1X PBS before incubation in
secondary fluorescent antibody at room temperature for 2 h (Alexa Fluor 488, 1:500;
Alexa Fluor 562, 1:500; Jackson ImmunoResearch, West Grove, PA). After 2 h, slides
were washed in 1X PBS before being cover-slipped using Vectashield mounting medium
(Vector Laboratories, Burlingame, CA) and imaged for GFP expression using fluorescent
microscopy

Statistics. All reinstatement experiments were analyzed with two-way ANOVAs with
repeated measures over reinstatement test days. Pairwise analyses were made with
appropriate post-hoc tests (p < 0.05).
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Results
AKAP signaling is required for the reinstatement of cocaine, but not sucrose seeking
AKAP signaling in the nucleus accumbens core has been implicated in the reinstatement
of cocaine seeking (Reissner et al., 2011). To confirm if these effects are also seen in
the accumbens shell, we microinjected a cell-permeable inhibitory peptide (St-Ht31) that
disrupts the binding of PKA to all AKAP isoforms into the nucleus accumbens shell of
rats that had previously self-administered cocaine and reinstated them with an acute
priming injection of cocaine (10 mg/kg, i.p.). Total active and inactive lever responses
(mean±SEM) are shown in Figure 1A (n = 9). These data were analyzed using a twoway ANOVA (both treatment and lever were within-subject factors), which revealed
significant main effects of treatment (F(1,8) = 34.46, p<0.001), lever responding (F(1,8) =
49.62, p<0.001), and a significant interaction between these variables (F(1,8) = 26.05,
p<0.001). Subsequent pairwise analyses indicated that the total active lever responses
between the St-Ht31 and St-Ht31P treatments were significantly different (Bonferroni,
p<0.0001).

Previous evidence suggests that intra-accumbal infusions of St-Ht31 do not affect
cocaine-induced locomotor activity (Reissner et al., 2011). However, AKAP150 mutant
mice lacking the PKA binding domain exhibit, among other things, deficits in operant
learning behavior (Weisenhaus et al., 2010). To determine if the effects of St-Ht31 impair
operant learning generally, we tested its effects on sucrose reinstatement. Total active
and inactive lever responses (mean±SEM) for rats pretreated with intra-accumbal shell
microinfusions of either St-Ht31 or St-Ht31P prior to reinstatement of sucrose-seeking
behavior are shown in Figure 1B (n = 8). These data were analyzed using a two-way
ANOVA which revealed no effect of treatment (F(1,7) = 1.726, p=0.23), a significant effect
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of lever responding (F(1,7) = 50.74, p<0.001), and no interaction between these variables
(F(1,7) = 1.472, p=0.26). The cannula placements are shown in Figure 1C.

AKAP signaling is required for D1DR agonist-induced reinstatement of cocaine seeking
Stimulation of D1DRs in the accumbens shell promotes the reinstatement of cocaine
seeking (Bachtell et al., 2005; Schmidt et al., 2006), an effect likely due to PKA
activation (Self et al., 1998). To determine if AKAPs are required for D1DR-stimulated
reinstatement of cocaine seeking, rats were pretreated with microinfusions of either StHt31 or St-Ht31P into the nucleus accumbens shell prior to intra-accumbal shell
injections of SKF-81297. Total active and inactive lever responses (mean±SEM) are
shown in Figure 2A (n = 5). These data were analyzed using a two-way ANOVA which
revealed significant effects of treatment (F(1,4) = 31.4, p<0.01), lever responding (F(1,4) =
13.48, p<0.05), and a significant interaction between these variables (F(1,4) = 33.57,
p<0.01). Subsequent pairwise analyses indicated that the total active lever responses
between the St-Ht31 and St-Ht31P treatments were significantly different (Bonferroni,
p<0.01). Cannula placements are shown in Figure 2B.

Expression of HSV-AKAP79∆PKA in the accumbens shell attenuates the reinstatement
of cocaine, but not sucrose seeking
Although there are over 50 different isoforms of AKAPs, AKAP150 is perhaps the best
characterized (Wong and Scott, 2004; Sanderson and Dell'Acqua, 2011). AKAP150 is
highly expressed in the striatum and plays a critical role in learning behaviors
(Ostroveanu et al., 2007; Tunquist et al., 2008; Weisenhaus et al., 2010). Additionally,
recent evidence suggests that AKAP150 expression is upregulated in the nucleus
accumbens after cocaine self-administration and extinction (Reissner et al., 2011).
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We sought to examine the role of AKAP150 in the reinstatement of cocaine seeking
behavior. Following self-administration and extinction, we expressed a humanized
dominant negative isoform of AKAP150 lacking the PKA binding domain and coexpressing GFP (HSV-AKAP79∆PKA) in the accumbens shell. As outlined in
experimental timeline illustrated in Figure 3A, the reinstatement session occurred 3 days
following viral microinjections (HSV-eGFP vs. HSV-AKAP79∆PKA), at peak HSV
expression (Neve et al., 2005) (Figure 3B). Total active and inactive lever responses
(mean±SEM) from the cocaine reinstatement session are shown in Figure 3C (n = 1013/group). These data were analyzed using a two-way ANOVA (virus treatment was a
between-subjects factor and lever a within-subject factor), which revealed no effect of
virus treatment (F(1,20) = 3.166, p=0.09), a significant effect of lever responding (F(1,20) =
111.7, p<0.0001), and a significant interaction between these variables (F(1,20) = 8.423,
p<0.01). Subsequent pairwise analyses indicated that the total active lever responses
between the HSV-eGFP and HSV-AKAP79∆PKA treatments were significantly different
(Bonferroni, p<0.01).

In order to determine if the disruption of PKA binding to AKAP150 affects general
operant behavior, we tested the effects intra-accumbal shell injections of HSVAKAP79∆PKA on sucrose reinstatement. Total active and inactive lever responding
(mean±SEM) from the sucrose reinstatement session are presented in Figure 3D (n =
7/group). These data were analyzed using a two-way ANOVA which revealed no effect
of virus treatment (F(1,12) = 0.01814, p=0.89), a significant main effect of lever responding
(F(1,12) = 26.99, p<0.001), and no interaction between these variables (F(1,12) = 0.01413,
p=0.91). The cannula placements are shown in Figure 3E.
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Expression of HSV-AKAP79∆PKA in the accumbens shell attenuates PKA-mediated
phosphorylation of GluA1 Ser845
Previous work showed that intra-accumbal injections of St-Ht31 attenuated GluA1
surface expression (Reissner et al., 2011). Since it is well-established that open
probability and surface expression of GluA1 are regulated by PKA phosphorylation
(Malinow, 2003), we examined the phosphorylation state of Ser845, a PKA
phosphorylation site on GluA1 AMPAR subunits, following intra-accumbal shell
administration of HSV-AKAP79∆PKA.

Total active lever responses (mean ± SEM) from the 30 min reinstatement session are
shown in Figure 4A. These data were analyzed using a two-way ANOVA (both virus and
treatment were between-subject factors), which revealed significant main effects of virus
(F(1,36) = 16.29, p<0.001), treatment (F(1,36) = 47.31, p<0.0001), and a significant
interaction between these variables (F(1,36) = 22.06, p<0.0001). Post hoc analyses
showed that total active lever responses were significantly different between GFP/Coc
groups and all other groups (Tukey, p<0.0001; n = 9-11/group).

The average intensity for pSer845 in the nucleus accumbens shell was expressed as
percent change from control and is shown in Figure 4B. Percentages were analyzed by
two-way ANOVA (both virus and treatment were between-subject factors), which
revealed no effect of virus (F(1,36) = 2.397, p=0.13), no effect of treatment (F(1,36) = 3.384,
p=0.07), but a significant interaction between these variables (F(1,36) = 4.332, p<0.05).
Post hoc analyses showed that the GFP/Coc group was significantly different from
GFP/Sal and AKAP/Coc groups (Tukey, p<0.05; n = 9-11/group).
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Since the AKAP79/150 α-helical motif binds to the PKA-RII regulatory subunit dimer
near the AKAP C-terminus (Sanderson and Dell'Acqua, 2011), we wanted to be sure
that deletion of this anchoring domain did not affect overall expression of the PKA-RII
subunit in the accumbens shell. The average intensity for PKA RII in the nucleus
accumbens shell was expressed as percent change from control and is shown in Figure
4C (n = 7/group). Percentages were analyzed by two-way ANOVA (both virus and
treatment were between- subject factors), which revealed no effects of virus (F(1,24) =
0.3518, p=0.56), treatment (F(1,24) = 0.1112, p=0.74), or interaction between these
variables (F(1,24) = 0.00374, p=0.95).

Expression of HSV-AKAP79∆PKA in the accumbens shell attenuates AMPAR currents
Given our biochemical findings that intra-accumbal shell administration of HSVAKAP79∆PKA attenuated phosphorylation of GluA1-Ser845, we sought to examine the
effects on AMPAR eEPSCs after reinstatement. Representative traces of eEPSCs from
AKAP+ and AKAP- cells are shown in Figure 5A. Quantification of this experiment is
depicted in Figure 5B. These data were analyzed with a two-sample t-test, which
revealed a significant difference in the size of the AMPA eEPSCs between the two
groups at 2x intensity (AKAP+: n = 9; AKAP-: n = 9; p=0.008) and 3x intensity (p = 0.03).
The rectification index was also assessed in both AKAP+ and AKAP- cells, which
revealed no significant differences between the two groups (p = 0.18, two- sample ttest). Additionally, we analyzed the AMPAR eEPSCs of rats treated with HSV-GFP. A
one-way ANOVA indicated no significant differences between AKAP- (n = 9), GFP+ (n =
7), and GFP- (n = 8) neurons at 2x (F(2,21) = 0.92, p=0.41) or 3x (F(2,21) = 1.23, p=0.31)
intensities.
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Discussion
Our results indicate that disruption of PKA binding to AKAPs, specifically AKAP150, in
the nucleus accumbens shell attenuates the reinstatement of cocaine seeking. We show
that AKAP150 promotes cocaine reinstatement by facilitating D1DR-induced, PKAmediated phosphorylation of GluA1-containing AMPARs. Collectively, these results
suggest that AKAP150 can bridge the dopamine and glutamate systems in the nucleus
accumbens to promote cocaine seeking.

The current findings support previous findings that nonspecifically disrupting PKA
binding to all AKAP isoforms in the nucleus accumbens attenuate cocaine reinstatement
(Reissner et al., 2011). Our results expand upon the previous findings as we show that
disruption of PKA binding specifically to the AKAP150 isoform attenuates cocaine
reinstatement. Additionally, our findings show that AKAP signaling is required for the
D1DR agonist-induced reinstatement of cocaine seeking. D1DR stimulation in the
nucleus accumbens, particularly the shell subregion, promotes cocaine reinstatement
(Schmidt et al., 2006) by increasing transmission through GluA1-containing AMPARs.
The C-terminal region of the GluA1 subunit of AMPARs can be phosphorylated by PKA,
Protein Kinase C (PKC), and calcium/calmodulin-dependent kinase II (CaMKII) (Derkach
et al., 2007; Anggono and Huganir, 2012), all of which contribute to the reinstatement of
cocaine seeking (Self et al., 1998; Anderson et al., 2008; Schmidt et al., 2013). In part,
D1DR stimulation reinstates cocaine seeking via serial activation of L-type calcium
channels and CaMKII (Anderson et al., 2008). Cocaine reinstatement is also associated
with D1DR-dependent increases in GluA1-pSer831, a PKC/CaMKII phosphorylation site,
as well as increased surface expression of GluA1-containing AMPARs (Anderson et al.,
2008). However, D1DR stimulation leads to cAMP and subsequently PKA activation,

84

which is linked to cocaine seeking (Self et al., 1998). Surprisingly, intra-accumbal
administration of a PKA inhibitor, Rp-cAMP, promotes the reinstatement of cocaine
seeking (Self et al., 1998). A potential explanation for this unexpected result is that RpcAMPs can also inhibit other cAMP-activated targets, such as exchange factors directly
activated by cAMP (Epacs) (Bos, 2006). Epac activation leads to increased levels of the
GTPase, Rap, which can interact with the Ras/ERK cascade to modulate ERKdependent processes (Lin et al., 2003; Johnson-Farley et al., 2005). There is
considerable evidence linking ERK activation in the accumbens core with cocaine
seeking (Edwards et al., 2011; Fricks-Gleason and Marshall, 2011). Our findings
suggest that AKAP150 is required for the appropriate subcellular targeting of PKA during
D1DR-mediated reinstatement of cocaine seeking.

In addition to a PKA binding domain, AKAP150 also contains a membrane-associated
guanylate kinase (MAGUK) motif that promotes its interaction with AMPA and NMDA
receptors via binding to scaffolding proteins, PSD-95 and SAP97 (Colledge et al., 2000;
Robertson et al., 2009; Sanderson and Dell'Acqua, 2011). Furthermore, AKAP150
enhances PKA-mediated phosphorylation of AMPARs, especially Ser845 on GluA1
subunits (Colledge et al., 2000; Tavalin et al., 2002). Our findings show that disrupting
the binding of PKA to AKAP150 attenuates GluA1-Ser845 phosphorylation and reduces
AMPAR eEPSCs. PKA phosphorylation of GluA1 at Ser845 leads to increased open
probability of AMPARs and increases surface expression of GluA1-containing AMPARs
(Banke et al., 2000; Malinow, 2003). In cultured accumbal neurons, D1DR stimulation
increases both Ser845 phosphorylation and GluA1 surface expression (Chao et al.,
2002a; 2002b). Consistent with these findings, cocaine reinstatement is attenuated by
intra-accumbal shell administration of AAV10-GluA1-C99, which impairs the trafficking of

85

GluA1-containing AMPA receptors to the cell surface (Anderson et al., 2008). Moreover,
withdrawal from cocaine self-administration leads to both increased GluA1 surface
expression, Ser845 phosphorylation, and increased rectification, which suggests an
increase in GluA1-containing, GluA2-lacking calcium permeable AMPARs (CPAMPARs) (Conrad et al., 2008; McCutcheon et al., 2011b). Our findings also support
previous work demonstrating that disrupting AKAP signaling in the nucleus accumbens
reduces GluA1 surface expression (Reissner et al., 2011). Surprisingly, in that study, no
change was observed in the phosphorylation status of GluA1-Ser845. However, there
are several methodological differences between the previous and current study, most
notably the biochemical findings of the previous study were observed in drug-naïve
animals. Additionally, stimulus-driven changes in GluA1-Ser845 phosphorylation can
enhance AMPA-mediated excitatory synaptic transmission and increase synaptic
localization of GluA1, partially through AKAP150-PKA binding (Lee et al., 2003; Man et
al., 2007; Qiu et al., 2014), whereas unstimulated changes in GluA1 surface expression
and AMPA transmission can be independent of basal Ser845 phosphorylation (Lee et
al., 2003; Lu et al., 2008; Sanderson et al., 2016).

Our findings also reveal decreases in AMPAR eEPSCs after disruption of PKA binding to
AKAP150. This is consistent with previous work showing that synaptic plasticity is
impaired in GluA1 KO mice, as well as S845A mutant mice that have impaired Ser845
phosphorylation and PKA-deficient AKAP150-D36 mice (Lee et al., 2003; Lu et al.,
2008). Additionally, disruption of PKA binding to AKAPs leads to downregulation of
AMPAR currents (Tavalin et al., 2002). Several studies also suggest that PKA binding to
AKAP150 and phosphorylation of GluA1-Ser845 can lead to increased surface
expression of GluA1-containing AMPARs, particularly CP-AMPARs (Qiu et al., 2014;
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Sanderson et al., 2016). However, we did not observe any significant reduction in
rectification index. Typically, CP-AMPAR accumulation in the nucleus accumbens is
linked to long-access (Mameli et al., 2009; Ferrario et al., 2010; McCutcheon et al.,
2011a; 2011b), but not short-access cocaine self-administration (Purgianto et al., 2013)
or experimenter-delivered cocaine (McCutcheon et al., 2011b). However, a recent study
illustrated that blocking CP-AMPARs in the nucleus accumbens attenuates the
reinstatement of cocaine seeking following a short-access paradigm (White et al., 2015),
though this effect was likely mediated through transient increases in GluA1 surface
expression as seen previously (Anderson et al., 2008; Schierberl et al., 2011). These
data demonstrate that AKAP150 facilitates GluA1-Ser845 phosphorylation and
increased AMPAR transmission, promoting cocaine reinstatement. Furthermore, this
suggests that during cocaine reinstatement there is synaptic incorporation of GluA1containing AMPARs, some of which may form CP-AMPARs, but most will likely form
GluA1A2 heteromers.

In addition to associating with AMPARs and NMDARs via its MAGUK domain, AKAP150
can also bind PKC (Klauck et al., 1996). PKC signaling plays a critical role in cocaine
reinstatement. Cocaine reinstatement is associated with increased PKC activation and
can be attenuated by intra-accumbal administration of PKC inhibitors (Schmidt et al.,
2013). Moreover, cocaine reinstatement is associated with increased GluA1-Ser831
phosphorylation (Anderson et al., 2008). PKC phosphorylates GluA1 subunits at Ser831,
facilitating GluA1 insertion into the membrane (Song and Huganir, 2002). AKAP150 can
also interact with L-type calcium channels via interaction with a leucine zipper domain at
its C-terminus (Oliveria et al., 2007). AKAP150 facilitates PKA phosphorylation of L-type
calcium channels at Ser1928, thereby increasing channel activity (Gao et al., 1997). This
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channel plays a major role in cocaine-induced synaptic plasticity and cocaine
reinstatement. Specifically, intra-accumbal shell administration of diltiazem, an L-type
calcium channel antagonist, attenuates the reinstatement of cocaine seeking
precipitated either by systemic cocaine injection or intra-accumbal shell administration of
the D1DR agonist SKF-81297 (Anderson et al., 2008). Though we did not investigate the
interactions between PKC, L-type calcium channels, and AKAP150 in this study, these
findings underscore the importance of AKAP150 as a major regulator of cocaine-induced
plasticity and cocaine craving.

The present results contribute to the growing body of literature indicating that increased
transmission through GluA1-containing AMPARs in the nucleus accumbens shell
promotes the reinstatement of cocaine seeking. Moreover, these data demonstrate a
compelling role for AKAP150 as a biochemical bridge linking the dopamine and
glutamate systems in the nucleus accumbens during cocaine reinstatement. These
findings suggest that AKAP150 may be a potential novel target for the development of
cocaine addiction pharmacotherapies.
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Figure 4. 1 Intra-accumbal shell mincroinjections of St-Ht31 attenuates cocaine, but not sucrose,
reinstatement. Mean (±SEM) active and inactive lever responses from (A) cocaine reinstatement
session, (B) sucrose reinstatement session. (C) Cannula placements from the nucleus
accumbens shell (dark circles). The values are in millimeters, relative to bregma. ***p < 0.001 StHt31 compared to St-Ht-31P Control. There were 8-9 animals per group.
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Figure 4. 2 Intra-accumbal shell mincroinjections of St-Ht31 attenuates D1DR-agonist induced
reinstatement of cocaine seeking. (A) Mean (±SEM) active and inactive lever responses from
reinstatement session. (B) Cannula placements from the nucleus accumbens shell (dark circles).
The values are in millimeters, relative to bregma. *p < 0.05 St-Ht31 compared to St-Ht-31P
Control. There were 5 animals per group.
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Figure 4. 3 Intra-accumbal shell expression of HSV-AKAP79∆PKA attenuates cocaine, but not
sucrose, reinstatement. (A) Schematic of experimental paradigm. (B) Representative image of
peak expression in the nucleus accumbens 3 days following HSV-AKAP79∆PKA injection. Three
days prior to the reinstatement test session, all animals received either HSV-AKAP79∆PKA or
HSV-GFP injections to the nucleus accumbens shell. (C) Mean (±SEM) active and inactive lever
responses from cocaine reinstatement session, (D) sucrose reinstatement session. (E) Cannula
placements from the nucleus accumbens shell (dark circles). The values are in millimeters,
relative to bregma. *p < 0.05 HSV-AKAP79∆PKA compared to HSV-GFP. There were 10-13
animals per group.
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Figure 4. 4 Intra-accumbal shell expression of HSV-AKAP79∆PKA attenuates GluA1-Ser845
phsphorylation. All animals received either HSV-AKAP79∆PKA or HSV-GFP injections to the
nucleus accumbens shell three days prior to the reinstatement test session. At the reinstatement
test session, all animals received either a saline or cocaine priming injection. (A) Mean (±SEM)
active and inactive lever responses from 30 min reinstatement session. (B) Decreases in GluA1Ser845 phosphorylation are measured by Western blot (see insets). (C) No change in PKA-RII
expression is observed by Western blot (see insets). ***p < 0.001, *p < 0.05 HSV-AKAP79∆PKA
compared to HSV-GFP. There were 9-11 animals per group.
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Figure 4. 5 HSV-AKAP79∆PKA reduces the recruitment of AMPA receptors following cocaine
reinstatement. (A) Representative traces from an AKAP79∆PKA-positive neuron (left) and an
uninfected neuron (right). A minimal intensity for eEPSC recruitment was obtained (1x) and then
increased to 2x and 3x this intensity. Arrowheads represent stimulation and the stimulation
artifacts of been removed for visual clarity. (B) Summary of the recruitment curves for
AKAP79∆PKA-positive (black circles, n = 9) and uninfected (red circles, n = 9) neurons. * p <
0.05.
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Chapter 5
GENERAL DISCUSSION AND FUTURE DIRECTIONS
Leonardo Antonio Guercio

Overview
Cocaine abuse poses a significant public health concern both in the United States and
across the globe. Cocaine is the fourth most commonly abused illegal drug in the world,
with the United States as the global leader in cocaine demand (Crime, 2016).
Approximately 1.5 million Americans aged 12 or older are regular users of cocaine,
comprising about 0.5% of the US population (Sarra L Hedden, 2015). Cocaine use is
also responsible for nearly 500,000 emergency room visits annually (National Institute
on Drug Abuse, 2016). A critical concern with cocaine abuse is the discouragingly high
rate of relapse among addicts following detoxification and abstinence, making it a
continuing public health concern that impacts our society, government, and healthcare
system (O'Brien, 1997).
Preclinical research using rodent cocaine self-administration and reinstatement
paradigms can elucidate the neurobiological underpinnings of human cocaine addiction
and relapse, potentially leading to the development of novel therapeutic interventions
that can reduce the burden of drug addiction on our society. The research presented in
this doctoral dissertation examined the influence of local and circuit-wide modulation of
the mesocorticolimbic reward system on cocaine reinstatement, an animal model of
relapse. In sum, the findings presented herein expand our understanding of the
neurobiological mechanisms underlying cocaine seeking and identify both a nonpharmacological application, deep brain stimulation (DBS), and a novel biochemical
target, AKAP150, for potential therapeutic interventions in cocaine addiction and craving.
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The data presented in the second and third chapters of this dissertation
demonstrated that DBS may serve as a possible non-pharmacological therapeutic
intervention in the treatment of cocaine addiction. In Chapter 2, I showed that DBS of the
nucleus accumbens shell attenuated the cue-induced reinstatement of cocaine seeking.
This expands upon our previous work showing that accumbal shell DBS attenuated
priming-induced reinstatement of cocaine seeking (Vassoler et al., 2008; 2013). In
Chapter 3, I demonstrated that DBS of the medial prefrontal cortex (mPFC), but not the
basolateral amygdala (BLA) or the ventral hippocampus (vHipp) selectively attenuated
the reinstatement of cocaine seeking. Moreover, this effect was constrained to the
infralimbic subregion of the mPFC as DBS in the prelimbic or anterior cingulate cortices
had no effect on cocaine reinstatement. My results also showed that infralimbic mPFC
DBS decreased zif268 immunoreactivity in the nucleus accumbens shell, suggesting
inactivation of glutamatergic cortico-accumbal projections. These findings bolster a
wealth of evidence suggesting that addiction causes a maladaptive response in the
circuit between the mPFC and the nucleus accumbens, and that this maladaptation can
be corrected through non-pharmacological manipulation (Chen et al., 2013; Stefanik et
al., 2013; Vassoler et al., 2013). Moreover, my findings demonstrate that in addition to
the nucleus accumbens, the mPFC may be an effective target for DBS in the treatment
of cocaine craving and relapse.
The data presented in Chapter 4 of this dissertation support a substantial body of
evidence demonstrating that increased transmission through GluA1-containing AMPA
receptors (AMPARs) in the nucleus accumbens shell promotes cocaine reinstatement.
Moreover, these data revealed the novel role of the protein, AKAP150, in the
reinstatement of cocaine seeking. My findings indicate that AKAP150 promotes cocaine
reinstatement by facilitating D1-like dopamine receptor (D1DR)-induced, PKA-mediated
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phosphorylation of GluA1-containing AMPARs. Taken together, these findings suggest
that AKAP150 may serve as a biochemical bridge linking the dopamine and glutamate
systems in the nucleus accumbens during cocaine reinstatement.

The development of novel pharmarcotherapies for cocaine addiction
Over the past decade, remarkable advancements have been made in both the
neuroscience of mental health and society’s awareness of mental illness. Despite these
advances, the treatment of mental illness remains a significant challenge. Mental illness
remains the leading cause of morbidity and mortality and psychiatric disorders constitute
five of the top ten causes of disability and premature death (Insel, 2009; Collins et al.,
2011; Bloom et al., 2012). Additionally, in 2010, the global cost of mental health
disorders was $2.5 trillion, an estimate that is projected to balloon to $6.5 trillion by 2030
(Bloom et al., 2012). Drug addiction is a complex mental health disorder and is among
the most prevalent neuropsychiatric disorders affecting modern society (Crime, 2016).
Discouragingly, despite decades of research, the core pathophysiological mechanism of
drug addiction remains unknown. A greater understanding of the neurobiological circuitry
and mechanisms underlying drug addiction will lead to improved pharmacotherapies.
Drugs of abuse mediate their initial reinforcing properties through dopaminergic
modulation of the mesocorticolimbic reward system. Despite their differing mechanisms
of action, all classes of addictive drugs (e.g. opiates, psychostimulants, alcohol, nicotine,
cannabinoids) increase dopamine (DA) transmission in mesocorticolimbic nuclei (Di
Chiara and Imperato, 1988), including the nucleus accumbens (Pierce and Kumaresan,
2006). The increase of mesocorticolimbic DA transmission as a common pathway for
drugs of abuse is consistent with the findings that DA encodes reward-prediction error
(Keiflin and Janak, 2015). However, the initial, acute actions of addictive drugs dissipate
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as the drugs are metabolized by the brain and therefore cannot explain the long-term
development of addictive behaviors. In 2001, a seminal study showed that a single
injection of cocaine sufficed to induce a long-lasting potentiation of excitatory
glutamatergic synapses onto VTA DA neurons (Ungless et al., 2001). Two years later,
this finding was also observed with other drugs of abuse, specifically amphetamine,
morphine, alcohol, and nicotine (Saal et al., 2003). These findings led to numerous
studies highlighting the importance of glutamatergic transmission and synaptic plasticity
in response to exposure to addictive drugs (Kauer and Malenka, 2007; Kalivas, 2009;
Schmidt and Pierce, 2010; Lüscher and Malenka, 2011). Taken together, these findings
revealed that both the dopamine and glutamate systems underlie the addictive
properties of nearly all drugs of abuse.
Currently, there exist effective, FDA-approved treatments for opioid, alcohol, and
nicotine addiction. However, despite decades of focused research, there are no FDAapproved pharmacotherapies for cocaine addiction. Initially, drugs that modulate the
dopaminergic system were assessed in both preclinical and clinical studies for the
treatment of cocaine addiction, based on the fact that all drugs of abuse increase DA
transmission in the mesocorticolimbic reward system. There was particular interest in the
D1DR antagonists, as they lacked the sometimes dangerous extrapyramidal side effects
observed with D2-like dopamine receptor (D2DR) antagonists (Haney and Spealman,
2008). These studies revealed that acute administration of D1DR antagonists attenuated
the reinforcing effects of cocaine (Romach et al., 1999; Platt et al., 2002). However,
clinical use of a D1DR antagonist requires repeated administration and cocaine addicts
treated with a D1DR antagonist, ecopipam, actually increased cocaine selfadministration (Haney et al., 2001). Another potential therapeutic for cocaine addiction
that showed promise was N-acetylcysteine (NAC). NAC, an FDA-approved treatment for
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acetaminophen overdose, reduced glutamate levels in the nucleus accumbens following
cocaine self-administration and cocaine reinstatement (Baker et al., 2002; 2003b). A
similar reduction in glutamate levels was observed in the prefrontal cortex of cocainedependent patients treated with NAC (Schmaal et al., 2012). However, in a double-blind,
placebo-controlled clinical trial, NAC failed to reduce cocaine use in actively using
cocaine-dependent individuals, though there was some evidence suggesting that it may
delay cocaine relapse in abstinent addicts (LaRowe et al., 2013). Collectively, these
clinical findings demonstrate that broad-based manipulations on dopamine or glutamate
signaling are not efficacious in the treatment of cocaine addiction.
Recent preclinical work has begun to examine a more nuanced interaction
between accumbal dopamine and glutamate systems in cocaine craving and relapse.
The nucleus accumbens is predominately made up of medium spiny neurons that
express either D1DRs or D2DRs (Gangarossa et al., 2013). Neurons in the nucleus
accumbens integrate information from dopaminergic and glutamatergic inputs stemming
from cortical and limbic structures to generate appropriate goal-directed behavioral
responses (Papp et al., 2012; Scofield et al., 2016). Stimulation of D1DRs in the nucleus
accumbens led to increased phosphorylation and surface expression of GluA1containing, or GluA2-lacking, calcium-permeable AMPARs (CP-AMPARs) (Chao et al.,
2002a; 2002b; Anderson et al., 2008; Ferrario et al., 2011; Hobson et al., 2013).
Interestingly, withdrawal from cocaine self-administration caused an increase in the
rectification index of D1- but not D2-containing medium spiny neurons in the accumbens,
suggesting an increase in CP-AMPARs in those cells(Pascoli et al., 2014). It should be
noted that while these studies have not identified effects in D2-containing medium spiny
neurons, previous work has shown that D2DRs and D2-containing medium spiny
neurons in the accumbens can regulate glutamatergic transmission and contribute to
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cocaine seeking (Bamford et al., 2004; Dani and Zhou, 2004; Bock et al., 2013; Ortinski
et al., 2015).
Signaling pathways activated by the dopamine and glutamate converge at the
post-synaptic density, a highly organized, macromolecular complex of synaptic proteins
that serve to process and integrate neural signals to the nucleus (Kennedy, 2000; de
Bartolomeis and Fiore, 2004). Synaptic proteins have been implicated in many
psychiatric disorders, including drug addiction (Kalivas and Volkow, 2005) and may
provide novel therapeutic targets (de Bartolomeis et al., 2014). The work encompassed
in Chapter 4 of this dissertation adds to the growing body of literature highlighting the
importance of synaptic proteins in the nucleus accumbens during cocaine reinstatement
(Reissner et al., 2011; Wiggins et al., 2011; Schmidt et al., 2013; Briand et al., 2014;
White et al., 2015). I showed that disruption of PKA binding specifically to the AKAP150
isoform attenuated cocaine reinstatement by reducing transmission through GluA1containing AMPARs in the nucleus accumbens shell. These findings, coupled with the
fact that AKAP150 is most highly expressed in the striatum (Ostroveanu et al., 2007) and
can also interact with both PKC and L-type calcium channels, both of which are critically
involved in cocaine seeking (Anderson et al., 2008; Schmidt et al., 2013), highlight the
potential therapeutic value of AKAP150 in the treatment of cocaine craving and relapse.

Non-pharmacological brain stimulation in the treatment of cocaine addiction
Over the past few years, the global pharmaceutical industry has significantly curtailed its
investment in drug development for psychiatric disorders, with some companies
shuttering their research programs entirely (Miller, 2010). Surprisingly, this retreat has
come despite the fact that psychiatric drugs have been extremely profitable for the
pharmaceutical industry, with 1 in 5 American adults currently taking at least one
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psychiatric drug (Hyman, 2013). This retreat can perhaps be explained by the significant
issues plaguing translational neuroscience and psychiatry: cellular and molecular
underpinnings of disease remain elusive, animal models provide poor face and
predictive validity, and validated biomarkers or other objective tests to aid in diagnosis
and treatment have not been found (Nestler and Hyman, 2010; Hyman, 2012). There are
several concerns with developing novel pharmacotherapies for substance use disorders
(Paul et al., 2010). First, the estimated development costs range from $4-11 billion, with
the entire process taking an average of over 13 years to complete. Second, the return on
investments for these new medications is poor, with large pharmaceutical companies
expecting to recover only 26 cents on the dollar, or a <0.3% return on new product
revenues. Finally, and perhaps most importantly, the lack of developmental efficiency is
troubling, with a measly ~7% approval rate of CNS compounds that make it to clinical
development. In fact, in 2015, the FDA approved 45 novel drugs, only 3 of which had
indications for nervous system disorders (CDER, 2016). Since drug addiction is a highly
prevalent neuropsychiatric disorder, these issues are a major cause for concern.
Currently, there are FDA-approved medications for drug addiction, specifically
opiate, alcohol, and nicotine addiction. While these medications are effective, they target
only certain aspects of the addictive process (Koob et al., 2009) and work best when
used in combination with social and behavioral interventions (Douaihy et al., 2013).
Importantly, there are no effective, FDA-approved pharmacotherapies for cocaine
addiction, despite rational drug development and well-controlled clinical trials (Pierce et
al., 2012). Drug addiction is a significant financial burden on our society, healthcare
system, and criminal justice system, with total costs exceeding $600 billion annually in
the United States alone (National Drug Intelligence Center, 2011). This underscores a
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critical need for effective non-pharmacological treatments, particularly for cocaine
addiction.
In April 2013, President Barack Obama announced the beginning of the BRAIN
Initiative (Brain Research through Advancing Innovative Technologies), a national,
collaborative, public-private research initiative, with the goal of supporting the
development of innovative technologies that would enhance our dynamic understanding
of the human brain. Importantly, this initiative also aims to further illuminate our
understanding of brain disorders in hopes of developing better treatments and improving
outcomes for patients with these disorders. The United States is not alone: the BRAIN
Initiative is part of a global effort by the G8 countries and others to further our
understanding of neuroscience and brain disorders (Grillner et al., 2016). One of the
high priority research areas for the BRAIN Initiative is the continued improvement of
existing technologies and development of novel technologies to modulate neural activity
(HHS, 2014).
Modulation of neural activity by electromagnetic brain stimulation is an active of
area of neuropsychiatric research. Since pharmacotherapeutics for psychiatric disorders
have limited effectiveness and are becoming increasingly expensive to develop (Hyman,
2013), recent efforts have focused on brain stimulation as a potential treatment modality.
At present, there are several different types of brain stimulation used medically. Chief
among them are electroconvulsive therapy (ECT), transcranial magnetic stimulation
(TMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS).
Electroconvulsive therapy (ECT), also known as shock therapy, works by electrically
inducing seizures in patients suffering from psychiatric disorders, particularly depression.
Unfortunately, ECT is associated with adverse events including cognitive impairments
and retrograde amnesia, and is thus used a last resort intervention for psychiatric
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disorders (Rudorfer et al., 2003). TMS has its roots in early 20th century Vienna, when
psychiatrists Pollacsek and Beer filed a patent to treat depression and other neuroses
with an electromagnetic device that resembled current TMS machines. However, the
modern TMS era began in the 1980s, when Tony Barker and colleagues developed a
focal electromagnetic device that could induce currents in the spinal cord (Barker et al.,
1985). They soon realized that this technology could allow them to non-invasively
stimulate the human brain. Briefly, TMS works by placing an electromagnetic coil on the
scalp of a patient. The electricity flowing through the coil creates a powerful (~1.5 Tesla),
but brief (microseconds) magnetic field that can pass through the skull and modulate the
electrical properties of neurons. Like TMS, tDCS is another non-invasive form of brain
stimulation. Though the principles underlying tDCS date back to the time of Luigi
Galvani, it was not seriously considered as a technique to modulate brain activity until
2000 (Nitsche and Paulus, 2000). tDCS works by applying constant weak (~1 mA)
electrical current through scalp electrodes. Unlike TMS, which can elicit action potentials
in cortical neurons, tDCS induces subthreshold changes in the membrane potential of
neurons, thereby more subtly increasing or decreasing the probability of eliciting action
potentials. DBS, originally developed in the 1950s, first achieved recognition in the
1980s as a potential therapeutic intervention for Parkinson’s disease and other
movement disorders (Benabid et al., 1987). Briefly, DBS involves implanting an
electrode deep in the brain and connecting it to a generator, located in the chest wall,
which sends constant electrical current into the brain. While DBS is an invasive
procedure, unlike TMS and tDCS, it allows physicians and scientists to target structures
deep in the brain, which is not possible with TMS and tDCS. Both TMS and DBS are
FDA-approved for treating and investigating neuropsychiatric disorders, while tDCS
remains an experimental treatment.
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These methods of brain stimulation have become increasingly examined as
potential therapeutic modalities for psychiatric disorders, particularly depression
(Kammer and Spitzer, 2012; George et al., 2014). TMS is FDA-approved for the
treatment of major depressive disorder. In 2010, a sham-controlled, randomized, multisite clinical trial demonstrated that TMS of the dorsolateral prefrontal cortex (dlPFC), as
a drug-free monotherapy, produced a significant anti-depressant effect in patients
(George et al., 2010) and lasted several weeks to months (McDonald et al., 2011;
Mantovani et al., 2012). A similar, albeit smaller, effect was seen using tDCS of the
dlPFC. Patients showed an improvement in mood as well as improvements in attention
and working memory (Loo and Martin, 2012). DBS of subcortical structures, including
the nucleus accumbens, has also been shown to demonstrate significant antidepressant
effects (Mayberg et al., 2005; Bewernick et al., 2010). In addition to treating depression,
these brain stimulation modalities have also been demonstrated to be effective in
treating other psychiatric disorders as well (George et al., 2014), particularly drug
addiction.
There is a growing body of evidence supporting brain stimulation as a potential
therapeutic modality for drug addiction (Salling and Martinez, 2016). TMS, tDCS, and
DBS have a wide range of effects across nearly all drug classes (e.g. alcohol, nicotine,
heroin, cocaine, and cannabis). However, since there are no effective
pharmacotherapeutic interventions for cocaine addiction, it is critically important to
examine whether brain stimulation can serve as a potential therapeutic modality. TMS of
the dlPFC and mPFC reduced both craving for cocaine and cocaine use (Camprodon et
al., 2007; Politi et al., 2008; Hanlon et al., 2015; Terraneo et al., 2016). Additionally, TMS
of the mPFC was shown to inhibit stimulus-evoked activity in the mPFC and decrease
activity in the striatum (Hanlon et al., 2015). The tDCS studies on cocaine addiction have
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primarily focused on cortical excitability and cognitive function (Conti et al., 2014; Gorini
et al., 2014). However, a recent randomized, double-blind clinical trial showed that tDCS
in the dlPFC reduced cocaine craving (Batista et al., 2015). These findings suggest that
TMS and tDCS may be preferable to DBS in treating drug addiction since they are noninvasive, unlike DBS. However, neither TMS nor tDCS can effectively target subcortical
structures. Furthermore, DBS is a one-time implantation surgery that can allow for
uninterrupted, hands-off, chronic stimulation as opposed to TMS and tDCS, which only
offer acute stimulation, with each session having to be done in the presence of a trained
medical professional. To date, there has been only one clinical study investigating the
effects of DBS on cocaine addiction, which showed that in a single patient, accumbens
shell DBS reduced his cocaine dependence based on both objective and subjective
measures (Gonçalves-Ferreira et al., 2016). The patient displayed significant clinical
improvement, in line with improvements seen with accumbal DBS in alcohol, heroin, and
nicotine addiction (Kuhn et al., 2009; Müller et al., 2009; Kuhn et al., 2011; 2014).
Collectively, these findings emphasize that brain stimulation may be a highly valuable
therapeutic modality in the treatment of drug addiction, especially cocaine addiction.
While there has only been a single, pilot clinical study investigating the role of
DBS in cocaine addiction, a wealth of evidence from animal studies suggest that DBS
may help treat cocaine craving and relapse. DBS of the nucleus accumbens shell, but
not the core or dorsal striatum, attenuated priming-induced reinstatement of cocaine
seeking (Vassoler et al., 2008; 2013). DBS of the nucleus accumbens also suppressed
locomotor sensitization to cocaine (Creed et al., 2015), another behavioral task that
reflects aspects of plasticity related to drug craving (Robinson and Berridge, 2001;
Steketee and Kalivas, 2011). The work encompassed in Chapter 2 of this dissertation
expands upon these findings, demonstrating that accumbal shell DBS also attenuates
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cue-induced reinstatement of cocaine seeking (Guercio et al., 2015). While nearly all
preclinical and clinical studies investigating DBS as a treatment for drug addiction have
focused on the nucleus accumbens, evidence from clinical studies using TMS and tDCS
suggest that the PFC may be a potentially effective target for DBS in treating cocaine
addiction. The work encompassed in Chapter 3 of this dissertation reveals that DBS of
the mPFC selectively attenuated the reinstatement of cocaine seeking. These findings
support previous claims that in addition to the nucleus accumbens, the mPFC may be
another effective target for DBS in the treatment of cocaine craving and relapse (Luigjes
et al., 2012).

The societal benefits of improved treatments for drug addiction
It is estimated that the total costs of substance abuse including productivity, health, and
crime-related costs, exceed $600 billion annually in the United States alone(National
Drug Intelligence Center, 2011). Given these prohibitively high costs, it is imperative to
enact sensible drug policies and legislation based on well-substantiated scientific and
public health research. In 2008, President Barack Obama reignited the Office of National
Drug Control Policy in an attempt to counteract the decades long, failed “war on drugs”
of previous administrations. The goal of the Obama administration was to restore
balance to drug control efforts by organizing an unprecedented coordination
government-wide public health, public safety, and scientific approaches to reduce drug
use and its consequences.
The unfortunate connection between drug use and crime is well known (National
Institute on Drug Abuse, 2014). There are 7 million adults involved with the criminal
justice system in the United States, both incarcerated and on probation (Glaze and
Herberman, 2013). Slightly more than half of all federal prisoners had a drug offense as
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their most grievous offense (National Institute on Drug Abuse, 2014). Further, 70% of
state prisoners and 64% of federal prisoners regularly used drugs prior to incarceration,
with 25% of violent offenders in state prisons having committed their crimes while
intoxicated (Mumola and Karberg, 2007). Untreated substance using offenders are far
more likely to relapse into drug use and criminal behavior, further taxing the public health
and criminal justice systems (National Institute on Drug Abuse, 2014). Treatment in
correctional settings followed by aftercare in the community when offenders are released
leads to substantial reductions in the rates of re-incarceration and the associated
criminal justice costs (McCollister et al., 2003a; 2003b). Additionally, the Obama
administration has reformed the judicial branch by creating drug courts. These are
special dockets designed specifically for non-violent offenders with a history of
substance abuse, allowing for continued, court-managed participation in treatment
programs to help reduce the rate of relapse associated with jail-time and recent parole
(Anon, 2015). In addition to relieving the criminal justice costs, improved drug policies
and drug treatment may also help to normalize racial disparities in drug convictions, as
African-Americans are far more likely than Caucasians to be convicted for drug-related
offenses (AnnCarson et al., 2015), despite equal rates of drug use (Sarra L Hedden,
2015).
Substance use also places a major financial burden on our healthcare system,
both for payers and providers. Patients with histories of substance use disorders have
elevated hospital and psychiatric admissions, substantially increasing total health care
costs (Clark et al., 2009). In 2010, the Obama administration passed the Affordable Care
Act, which includes substance use rehabilitation as an essential component of health
care. This is a significant benefit for people with substance use disorders as they are far
more likely to be uninsured compared to the national average (Bouchery et al., 2012).
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Since the loss of insurance benefits is associated with restricted access to care and the
closure of drug abuse treatment centers (Bret E Fuller et al., 2006; Deck et al., 2006),
the Affordable Care Act is a welcome respite to those struggling with substance use
disorders. Further, treatment for substance use disorders can lead to reduction in the
utilization and cost of medical care (Walter et al., 2005).
Improving treatments for those struggling with addiction is not only our moral and
ethical responsibility, it is also financially prudent. The economic benefits of investing in
drug treatment exceed the costs of treatment, with cost-benefit analyses showing that
every dollar spent on care returns 7 dollars in benefits (Ettner et al., 2006). These
treatment benefits include increases in employment income and decreases in avoided
costs of criminal activities, incarceration, and hospitalization (Ettner et al., 2006).

Concluding Remarks
The work encompassed in this doctoral dissertation demonstrates that local and circuitwide manipulations of the mesocorticolimbic reward system can modulate the
reinstatement of cocaine seeking. There is a substantial body of literature indicating that
DBS of the nucleus accumbens may be a potential therapeutic modality in the treatment
of cocaine addiction. Specifically, DBS of the nucleus accumbens shell, but not the core
or dorsal striatum, attenuates the priming-induced reinstatement of cocaine seeking
(Vassoler et al., 2008; 2013). The present results expand upon this finding by showing
DBS of the nucleus accumbens shell also attenuated cue-induced reinstatement of
cocaine seeking (Guercio et al., 2015). The work herein also revealed a novel target
brain region for DBS in the treatment of cocaine addiction: DBS of the infralimbic mPFC
selectively attenuated the reinstatement of cocaine seeking. These findings are
consonant with results from other therapeutic modalities, such as TMS and tDCS,
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suggesting that mPFC stimulation can reduce cocaine use and craving (Batista et al.,
2015; Hanlon et al., 2015; Terraneo et al., 2016).
It is now clear that cocaine reinstatement is associated with changes in
dopamine and glutamate transmission in the nucleus accumbens (Schmidt et al., 2005;
Schmidt and Pierce, 2010). Further, it has been shown that cocaine reinstatement
promotes modifications of glutamatergic receptors and associated proteins, causing
altered excitatory transmission in the nucleus accumbens, (Pierce and Wolf, 2013). The
results of this dissertation expanded upon this knowledge identifying a necessity for the
protein, AKAP150, which acts as a biochemical bridge between the dopamine and
glutamate systems to promote the reinstatement of cocaine seeking. These findings
present AKAP150 as a potential novel pharmacotherapeutic target in the treatment of
cocaine craving and relapse. Since broad-based manipulations of dopamine and
glutamate transmission have failed to produce effective pharmacotherapies for cocaine
addiction, drugs that manipulate synaptic proteins to indirectly modulate receptor
functioning may prove more fruitful in selectively combating addictive behaviors.
Finally, this dissertation addressed why we, as a nation, must invest in improved
drug treatments and advocate for sensible drug policies. Improving treatments for those
struggling with addiction is not only our moral and ethical responsibility, it is also
financially prudent (Ettner et al., 2006). Given the significant burden drug addiction
places on our society, healthcare, and criminal justice systems, it is imperative that we
tackle this challenge using scientific, legal, and socioeconomic approaches. It is
assuredly a difficult task, but as Benjamin Franklin, founder of this great University
wisely stated, “without continual growth and progress, such words as improvement,
achievement, and success have no meaning.”
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